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Discodermolide was discovered in 1990 and with its discovery set off an expansive 
medicinal chemistry program fueled by many groups’ research.  It acts as a microtubule 
stabilizer, which makes it a potential anti-cancer agent.  The synthesis of simplified 
discodermolide analogs is reported here.  These analogs use simplified versions of the lactone 
and carbamate fragments, which are then coupled via olefin metathesis.  Hologram quantitative 
structure-activity relationship (HQSAR) is also used to show that an olefin linker inserted by  
olefin metathesis as viable simple alternatives to the complex middle portion usually found in the 
parent molecule. 
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1.0  INTRODUCTION 
Discodermolide 1 (Figure 1) was first discovered in 1990 by researchers at the Harbor Branch 
Oceanographic Institution, Inc. from the marine sponge Discodermia dissoluta.1 The molecule is 
a complex polyketide containing thirteen stereocenters, four double bonds (a terminal diene and 
two internal Z-olefin linkages), four hydroxy groups, a δ-lactone and a carbamate.  The first 
biological screens of the molecule identified discodermolide as a potential immunosuppressive 
agent.1  Initial studies compared discodermolide with the immunosuppressive agents cyclosporin 
A and FK506 (a novel immunosuppressive agent at the time, now known as tacrolimus).  In vitro 
studies showed that discodermolide was nearly as potent in suppressing proliferation in a mixed 
lymphocyte reaction assay as cyclosporin A, but not as potent as FK506.2  Follow-up in vivo 
studies identified discodermolide to be more potent than cyclosporin A.3  The relative 
configuration of discodermolide was elucidated by using an acetylated form of the molecule by 
1D and 2D NMR techniques,1 but the absolute stereochemistry was unknown for some time.  
Although the potential for discodermolide as a drug was exciting, the excitement was tempered 
because it represented only 0.002 % by weight of the Discodermia sponge.1  The supply 
problem, as well as the potential of discodermolide as an active compound, led many groups to 
undertake its total synthesis and pursue further biological studies. 
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Figure 1- (+)-Discodermolide and its constituent moieties.  Stereotriad is identified by starts. 
 
1.1 EARLY SYNTHETIC STUDIES 
The first total synthesis of discodermolide was reported in 1993 by the Schreiber group.4 The 
synthesis began with the now common disconnection of discodermolide into three fragments 5, 
6, and 7 (Figure 1 and Figure 2), all of which contain the same syn, anti, methyl-hydroxy-
methyl stereotriad (stars in figure 1).  The three fragments are separated by the double bonds at 
C8-9 and C13-14. The synthesis by Schreiber used a common starting material, the enantiomers 
of 3-hydroxy-2-methylpropionate 2 (a.k.a., Roche ester), to synthesize both the (–) and the (+) 
enantiomers of the natural product in a highly convergent synthetic scheme (Figure 2).5,6  From 
the starting ester, they made two homoallylic alcohols 3 and 4 that could be transformed into 
fragments containing the C1-C7 lactone 6, C8-C15 linker 5, and the C16-C24 carbamate 7 
(numbering for discodermolide begins with the lactone carbonyl group, see figure 1).  A revised 
strategy called for coupling of the lactone and linker portions via a Nozaki-Kishi reaction, and 
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then an alkylation with the E-enolate at C16 and the combined lactone-linker portion.  With both 
enantiomers of 1 in hand, Schreiber identified (+)-discodermolide as the natural product by 
comparison of optical rotation values of the synthesized enantiomers to the value reported by 
Gunasekera.  Also, Schreiber compared the anti-proliferative potencies of the synthesized 
compounds to the isolated compound to confirm (+)-discodermolide as the correct enanatiomer.5  
The first total synthesis of 1 was completed in 36 total steps, with a yield of 4.3 % over a 24 step 
longest linear sequence.6   
 
 
Figure 2- Schreiber Synthesis of (+)-Discodermolide, the Correct Enantiomer of the Natural Product 
1.2 SYNTHETIC WORK OF DISCODERMOLIDE 
Following Schreiber’s total synthesis, many other groups worked on discodermolide synthesis.  
Four total syntheses have been completed by Amos Smith’s group.7  Their syntheses use a 
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“common precursor” to synthesize three fragments that contain the stereotriad of discodermolide 
starting from Roche’s ester 2.  The result of the first synthesis was the antipode of 
discodermolide.7  In 1999, Smith published a synthetic route that resulted in one gram of the 
natural form of discodermolide using the common precursor scheme as before with the correct 
enantiomer of Roche ester as the starting material (Figure 3).8  Briefly, the common precursor 
synthesis began with para-methoxybenzyl protection of the primary alcohol 2 to yield ether 8.  
The ester moiety of 8 is reduced with lithium aluminum hydride to yield 9.  Alcohol 9 is 
oxidized with Swern conditions to yield aldehyde 10.  Aldehyde 10 undergoes an Evans syn-
aldol condensation with 11 to yield 12.  Finally, 12 is transformed to Weinreb amide 13 with 
treatment of trimethylaluminum.  The Evans auxiliary 11 can be recycled, which helps in the 
scale-up of the synthesis.  They improved on their initial synthesis by employing only 24 steps in 
the longest linear sequence, and 6 % overall yield.  A third approach was disclosed in 2003,9 and 
in 2005 a fourth approach was reported that reduced the total number of steps (longest linear 
sequence 17 steps) and increased the overall yield to 9%.10  Novartis Pharma, needing many 
grams of discodermolide to perform clinical trials, used Smith’s common precursor 13 to make 
the three fragments of discodermolide.  This was followed by coupling methods found in the 
syntheses by Smith and Paterson.  This impressive feat resulted in 60 g over 39 steps and 
required only 17 chromatographic purifications, allowing Novartis to begin clinical trials of 
discodermolide as a potential anti-cancer medicine.11–15 
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Figure 3- Common Precursor Synthetic Scheme used by Smith and Novartis for Scale-up Synthesis 
 
In a first  synthesis,16 the Paterson group made discodermolide with an overall yield of 
10.3% over 23 steps for the longest linear sequence (42 steps overall).16  The same group 
reported two other total syntheses of discodermolide.  The 3rd route completes discodermolide in 
an overall yield of 11.3% from the chiral Roche ester.17 The Myles group reported a total 
synthesis of the enantiomer of discodermolide in 199718 and followed that with the preparation 
of the naturally occurring compound in 2003.19  Marshall and Johns disclosed their total 
synthesis of discodermolide in 1998.20  Arefalov and Panek reported a total synthesis of 
discodermolide in 2005 in 42 steps with 2.1 % overall yield.21  The Ardisson group published a 
total synthesis in 2008 that completed the natural product in a 21-step longest linear sequence in 
a yield of 1.6 %.22  These innovative total syntheses testify to the importance of discodermolide 1 
as a drug candidate, since many groups devised ways to make the natural product. 
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1.3 MECHANISM OF ACTION AS A MICROTUBULE STABILIZER 
1.3.1 The Microtubule System and Discodermolide 
Microtubules are a crucial part of the cytoskeleton that has a role in many cellular functions.  
These hollow tubes consist of polymerized α, β tubulin heterodimers organized into thirteen 
protofilaments that form a 25 nm inner diameter tube (Figure 4).  Tubulin is a 55 kDa protein 
that appears in 5 isoforms (α, β, γ, δ, and ε).  Two isoforms (α and β) make up the majority of the 
protein found in cells.  Microtubules have the ability to grow up to a few micrometers in length 
or to shrink depending on the need at a particular moment.  During mitosis, microtubules 
undergo rapid polymerization/depolymerization to search and capture kinetochores (the center of 
chromatids available for microtubule attachment) of sister chromatid pairs during prometaphase 
of mitosis.  Cells cannot undergo normal division until all chromosomes are attached and able to 
be separated by the two microtubule-anchoring centrosomes.  Microtubule-perturbing agents act 
during this stage, causing cell-cycle arrest and apoptosis.23 Because microtubules are crucial for 
cell division, they are validated targets for cancer drugs. 
Drugs that target the microtubule system fall into two categories: microtubule stabilizers 
and destabilizers.  Microtubule destabilizers, such as colchicine and the vinca alkaloids, act by 
arresting the polymerization of microtubules and disrupting the dynamics of the system.24  
Microtubule stabilizers act by inhibiting the depolymerization of microtubules. The inhibition 
arrests mitosis because of microtubule bundling and inhibition of the search and capture 
mechanism needed to separate sister chromatid pairs.25  The best studied microtubule-stabilizing 
agent is paclitaxel, a compound whose mechanism of action was determined in 1979.26  
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Paclitaxel, used clinically as an anticancer drug, binds to polymerized microtubules and causes 
cell cycle arrest but exhibits some problems as a drug due to low solubility.   
 
 
Figure 4- Formation of Microtubules by the α,β tubulin heterodimer (Reprinted by permission from 
Macmillan Publishing Ltd: Nat. Rev. Cancer, 2004, 4, 253-265.  Copyright 2004) 
 
1.3.2 The Mechanism of Action of Discodermolide 
In conjunction with the synthesis the synthesis of both antipodes of discodermolide, Schreiber 
first reported in 19945 that both enantiomers arrested the cell cycle of MG63 human osteoblasts, 
but in different phases.  The natural (+)-antipode arrests the cell cycle in the G2/M (mitosis) 
phase, while the unnatural (-)-antipode arrests the cell cycle in the S (synthesis) phase. 
A QSAR (quantitative structure-activity relationship) screen of multiple libraries looking 
for molecules with potential microtubule-perturbing activity by the Day group unexpectedly 
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identified discodermolide as a possible microtubule stabilizer.27  The Day group then performed 
initial in vitro studies that showed that discodermolide acted as a microtubule stabilizer.28  
Microtubule stabilizers at that time included only paclitaxel, docetaxel and the epothilones, but 
since then the class has grown to include dictyostatin and several others.  Although structurally 
diverse, all of these microtubule-stabilizing agents have shown strong preclinical activity as 
potential anti-cancer therapeutics.25   
The Day group compared discodermolide and paclitaxel in cell assays.  The GI50 (50% 
growth inhibition of cells) value was 2.4 nM for discodermolide compared to 2.1 nM for 
paclitaxel in the estrogen-responsive cell line MCF-7.  A turbidity assay was performed to 
investigate the ability of discodermolide to alter the assembly of tubulin in vitro (Figure 5).  
Discodermolide caused tubulin assembly at 0 °C in the presence of microtubule associated 
proteins and GTP (Figure 5, curve 3).  Without test agents, polymerization occurs at 37 °C 
(Figure 5 curve 1), and at about 17 °C when paclitaxel is added (Figure 5, curve 2).  Also, the 
discodermolide-induced polymer does not disassemble when the temperature is dropped to 0 °C, 
unlike test agent-untreated and paclitaxel-treated microtubules.28  It was also confirmed by Day 
that (+)-discodermolide arrests MCF-7/LY2 breast carcinoma cells in the G2/M phase of the cell 
cycle, confirming the findings of Schreiber.29 
. 
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Figure 5- Turbidity Assay Result Comparing Discodermolide (3), Paclitaxel (2) and Untreated 
Microtubules (1). (Adapted with permission from ter Haar et al. Biochemistry, 1996, 35 pp243-250.  Copyright 
1996, American Chemical Society) 
 
Discodermolide also shows activity as an anti-proliferative agent in multi-drug resistant 
cells and retains potency against paclitaxel-drug resistant cancer cell types.30  In SW620 colon 
carcinoma cells, discodermolide is about 10-fold less potent than paclitaxel.  But in the multi-
drug resistant variant of the same cell line, discodermolide is 4-fold more potent than paclitaxel.  
This is because discodermolide is not a substrate for the P-glycoprotein efflux pump, while 
paclitaxel is a substrate.  Additionally, in a variant of 1A9 ovarian cancer cells that need 
paclitaxel to survive, discodermolide is not a substitute of the drug, and cells are not viable.  
Epothilone B, another microtubule stabilizing, can substitute for paclitaxel and allows for cell 
viability.30     
 Discodermolide causes cell death in breast carcinoma cells via an apoptosis mechanism.31  
This is the case with both estrogen dependent and independent cell types.29  Treatment with 
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discodermolide in A549 cells results in shorter microtubules and more bundles as well as the 
induction of accelerated cell senescence.32 Accelerated cell senescence is a unique finding for 
discodermolide treatment compared to treatment with other microtubule stabilizers.33,32  Recent 
studies trying to pinpoint the mechanism of cell death with discodermolide treatment show that 
usual apoptotic cell markers are not up-regulated in cells after discodermolide treatment.34  
Additionally, a discodermolide-resistant cell type has been isolated in which the level of the 
protein 4E-BP1 is decreased.35  This protein is important for accelerated cell senescence, so it is 
believed that resistance to discodermolide can be obtained by decreasing the incidence of this 
cell mechanism.   
1.3.3 Discodermolide Activity in Combination with Other Agents 
Discodermolide binds microtubules differently from other microtubule stabilizing agents; 
discodermolide shows a higher affinity for the taxane-binding site on β-tubulin than paclitaxel.  
In competition binding experiments with [3H]-paclitaxel, discodermolide displaces paclitaxel 
from the binding site and forms shorter microtubule polymers at a faster rate.30  Despite these 
differences and the higher affinity of discodermolide for the paclitaxel binding site, 
discodermolide and paclitaxel act synergistically when used in tandem against ovarian, breast, 
and lung cancer cells.36,37  This synergy was unexpected, because discodermolide displaces 
paclitaxel from microtubules in competition binding experiments.  Discodermolide does not act 
synergistically with other microtubule stabilizing agents that bind in the paclitaxel or other 
sites.38  In studies of the effect of microtubule destabilizing agents in pre-stabilized microtubules, 
discodermolide-stabilized microtubules resisted the destabilizing tendencies of many 
microtubule destabilizing agents better than paclitaxel- or epothilone B-stabilized microtubules.39 
 11 
Although discodermolide performed well in many in vitro assays and showed many 
positive characteristics that differ from classic microtubule stabilizing agents, Novartis halted 
studies of discodermolide in Phase I/II clinical trials due to pneumotoxicity.40  This lessened the 
interest in the development of discodermolide as a clinical candidate, but increased interest in the 
synthesis of analogs that may not have the toxicities associated with the natural product. 
1.4 CONFORMATIONAL ANALYSES OF DISCODERMOLIDE 
The desire to determine how discodermolide binds in microtubules led to great number 
conformational studies.  Several microtubule stabilizers with very different structures were 
discovered at about the same time as discodermolide, so a link between all the compounds of this 
class was sought.  In 1999, it was hypothesized that discodermolide, paclitaxel, docetaxel and the 
epothilone family fit a common pharmacophore model for the paclitaxel binding site.41  Using 
molecular dynamics simulations, the important aspects needed for binding were proposed to be 
the lactone region, the C13-C14 area, and the terminal double bond.  Even with a possible 
common pharmacophore model, the lack of a co-crystal structure of discodermolide in the α, β 
tubulin dimer led to more studies aimed at discovering the exact binding mode and conformation 
of discodermolide.  In 2001, the Smith group matched NOE peaks from a ROESY 2D spectrum 
of discodermolide with corresponding energy minimized conformations of molecules to give a 
solution structure of discodermolide in acetonitrile.  The Smith group (or The same group) found 
that discodermolide in solution closely resembles the conformation of discodermolide in the 
crystalline state (Figure 6). Despite the many rotatable bonds, the solution preference of 
discodermolide for a fairly rigid hairpin type conformation was rationalized by the A1,3 strain at 
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C13-16 and C8-10, as well as syn-pentane interactions in the backbone at C10-12, C16-C18 and 
C18-C20.42   
 
 
Figure 6- Discodermolide Crystal Structure that Shows the Hairpin Structure (Adapted with 
permission from The Journal of Organic Chemistry, 1990, 55, pp 4912-4915, Copyright 1990, American Chemical 
Society) 
 
 Shortly after the solution-based study by Smith, Snyder and co-workers employed 1D 
and 2D NMR experiments to find the conformation of discodermolide in DMSO and correlated 
the data with the modeling protocol NAMFIS (NMR analysis of molecular flexibility in 
solution).43  Whereas in acetonitrile only one general conformation is put forth, Snyder specifies 
12 conformations that were possible for discodermolide in DMSO.  These conformations were 
classified into three groups.  The most populated conformation was called a corkscrew, in which 
the molecule forms a helical shape.  This general shape occurred 58% of the time, and is the 
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closest in resemblance to the hairpin conformation set forth by Smith.  The two other less 
populated shapes were the sickle and extended forms of the molecule. 
The Carlomagno and Jimenez-Barbaro groups then determined the conformation of 
discodermolide bound in soluble tubulin in DMSO44 and  in D2O.
45  Discodermolide kept the 
hairpin conformation identified by Smith upon binding to β-tubulin as determined by 2D NMR 
experiments.  Snyder and co-workers revisited their binding conformation using four force fields 
for modeling experiments of the bound-conformation of discodermolide instead of just one used 
previously.  In this instance, Snyder’s results more closely resembled the conformations that are 
found in both D2O and acetonitrile.  Indeed, they find that the X-ray motif shows up more than 
50 % of the time in the NAMFIS calculations.46  Although these studies differ in various aspects, 
there is a steady consensus that the hairpin conformer of discodermolide is important. 
1.4.1 Docking Studies of Discodermolide 
Two potential taxane binding sites on β-tubulin are hypothesized; an inner luminal site 
that is the major site for activity of the taxanes, and a possible pore site found on the outside of 
formed microtubules.47  Because many microtubule stabilizing agents only bind to polymerized 
microtubules, one hypothesis states that microtubule stabilizing agents bind first to the external 
pore site, and then move to the internal luminal site as a final resting place.  This hypothesis is 
supported by two observations.  First, a fluorinated analogue of paclitaxel, hexaflutax, has 
trouble entering the luminal site on β-tubulin, instead stopping at the pore site.48  A second 
experiment uses cyclostreptin, a microtubule stabilizing agent that binds covalently to β-tubulin.  
Using mass spectrometry techniques, researchers found that cyclostreptin was bound to peptides 
in both the pore and the luminal sites.49   
 14 
It is not yet known whether discodermolide binds at the pore or luminal taxane binding 
site.  Canales and co-workers used 2D NMR conformational studies and the program 
AUTODOCK to generate the first binding pose/model of discodermolide in β-tubulin.45  In this 
model, important polar contacts occur with His229, Pro274, Thr276, Ser277, Gln282 and Gly330 
(blue molecule, figure 7) in the luminal site of β-tubulin, with the lactone and carbamate being 
responsible for many of these contacts.  The Snyder group used their own conformational studies 
to dock discodermolide into the taxane binding site.46  They used three programs to generate 
binding poses; Glide, RosettaLigand and AUTODOCK (v 4.0).  In addition to the pose generated 
by Canales, they generated a pose that flips discodermolide in the luminal binding pocket, 
making the linker region exposed to solvent rather than making contacts with the protein (green 
molecule, Figure 7).  The residues identified in the second pose show Pro272, Thre274 and 
Arg276 making important contacts with the C3 hydroxyl, the C17 hydroxyl and the C19 nitrogen 
of the carbamate. 
 
 
Figure 7- Two Distinct Poses of Discodermolide in the Taxane Binding Site (Reprinted with permission 
from the Journal of Medicinal Chemistry vol 53, 2010, pp 155-165.  Copyright 2010, American Chemical Society) 
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The Xiao and Horwitz groups used hydrogen-deuterium exchange (HDX) experiments 
followed by LC-ESI-MS analysis and then SURFLEX docking to identify and confirm the amino 
acid residues in the binding pocket for discodermolide.50  The investigators found that the amino 
acids that are protected from deuterium incorporation upon binding with paclitaxel and 
discodermolide are very different.  They also find that some of the amino acids that Canales 
described as contacts in pose-1 (blue, figure 7) are not blocked from deuterium incorporation.  
Based on results from the HDX experiments, they found that discodermolide binds best in the 
taxane binding pocket instead of the pore site. Contacts are made between the C19 nitrogen of 
discodermolide and Leu361 and Gly360, between the C7 hydroxyl group and Asp224, and the 
C11 hydroxyl and Glu22.    
1.5 SYNTHETIC ANALOGS OF DISCODERMOLIDE 
 
Although discodermolide shows potent activity in cell-based assays, researchers have 
synthesized analogs to attempt to make a compound that could become a drug.  A thorough 
structure-activity relationship (SAR) has been developed based on hundreds of analogs.  Analogs 
can be classified into categories based on the fragment of discodermolide that was modified (see 
Figure 1).  The categories include derivatives of the lactone fragment, derivatives of the linker 
fragment, derivatives of carbamate fragment, and hybrid analogs of discodermolide with other 
microtubule stabilizers. 
Gunasekera and coworkers contributed some of the first analogs of discodermolide 
through semi-synthesis and by isolating analogs from natural sponge sources of the Discodermia 
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family.  Acetylation of the C17 and C11 hydroxyl positions decreases activity compared with 
discodermolide, but acetylated versions at C3 and C7 hydroxyl positions retain potency close to 
the parent molecule.51,52  Natural analogs isolated consisted of the C2 epimer of the parent 
molecule, a C2 desmethyl analogue, a C19 desaminocarbonyl analogue, the open chain form of 
the δ-lactone, and the C9-C13 cyclopentane form of discodermolide.53  All of these analogs had 
nanomolar activity in anti-proliferative assays except for the cyclopentane modification which 
was only weakly active.  Following the work of Gunasekera, many more analogs were made by 
total synthesis that contained changes the three regions of discodermolide. 
1.5.1 Analogs of the Lactone Fragment  
The area of discodermolide that has been targeted the most for potential improvements or 
simplification is the lactone region (SAR is summarized in Figure 8).  Analogs typically alter 
individual positions on the lactone ring or replace the δ-lactone moiety entirely.  An α, β-
unsaturated lactone (removal of the C3-OH and C2-methyl group)  made by Smith showed the 
same potency as the parent molecule in cell based assays.33  This was the first significantly 
simplified lactone that retained potency similar to discodermolide.  
Complete replacement of the δ-lactone fragment of discodermolide with simpler lactones 
was tested soon after by a Smith group/Kosan Biosciences collaboration.  Favorable groups 
included the five-membered butyrolactone 14, which showed better activity in cell-based assays 
than the parent molecule.54  Another possible replacement of the δ-lactone is a coumarin group 
15, which also has higher potency than discodermolide.55  Additionally, a phenol group 16 in 
place of the lactone retained potency seen near the parent molecule.54  Based on the activity of 
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these analogs, a hypothesis was stated that the carbonyl of the lactone ring is the important 
aspect of discodermolide binding to microtubules. 
 
 
Figure 8- SAR of the Lactone Ring of Discodermolide and Possible Replacement Groups 
 
1.5.2 Analogs of the Carbamate Fragment 
The SAR of the carbamate fragment is summarized in Figure 9; Changes were made to the 
carbamate region of discodermolide at the terminal diene, the C19 carbamate, the C17 hydroxyl 
position and various methyl groups. The terminal diene was appended with extensions for 
possible photo-analogs or fluorescent probes.  These extensions did not decrease activity of the 
molecule.6   In addition to appendages to the terminal diene, saturating the C23-C24 double bond 
led to an improvement of activity.  Although the C23-C24 bond can be saturated, the Z C21-C22 
double bond is necessary to keep the potency discodermolide.56 
Smith and colleagues again added to the SAR of discodermolide when they prepared 
analogs with bulkier C19 carbamate moieties.57  A wide range of phenyl carbamate analogs were 
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advantageous in terms of biological activity in normal cells but not in multi-drug resistant cell 
lines.  Analogs with bulky carbamate groups were less potent when compared to discodermolide.  
The only carbamate that allowed for retention of activity against multi-drug resistant cells was an 
aniline carbamate moiety.57  
Positions modified include the C17 hydroxyl position and the methyl groups at C16 and 
C14.  In the synthesis of discodermolide by Schreiber, it was reported that the epimer of C17 OH 
as has low activity.5  Schreiber reported that the C16 desmethyl analogue was almost as potent as 
the parent molecule.6  The C14 desmethyl form of discodermolide, reported by Smith, shows 
good activity, but not as good as discodermolide.33   
 
 
Figure 9- SAR of the Carbamate Fragment of Discodermolide 
 
1.5.3 Analogs of the Linker Fragment 
Although the two end regions of discodermolide have been investigated thoroughly, the linker 
fragment has not been investigated to the same extent.  Analogs with a connection between C9 
and C13 on the discodermolide backbone (Figure 10) were isolated by Gunasekera as 
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byproducts after the final deprotection step during the Novartis synthesis of discodermolide. The 
analogs had lower activity than discodermolide.58  Smith synthesized two diastereomeric C13-14 
cyclopropyl analogs of discodermolide.  These analogs had some activity, but not near the level 
of discodermolide.59  Finally, Gunasekera also reported that the C8-C9 bond can be saturated 
without affecting activity, whereas saturation of the C13-C14 double bond causes loss of activity 
compared to discodermolide.53 
 
 
Figure 10- SAR of the Linker Region of Discodermolide and Other Additions 
 
1.5.4 Dictyostatin 
In 1994, the marine natural product dictyostatin 17 (Figure 11) was isolated by Pettit and 
colleagues from the marine sponge Spongia family.60 Although dictyostatin is a macrocycle, the 
backbone of dictyostatin matches up to the C8-C24 backbone of discodermolide, minus the C13-
14 olefin and the C16 methyl group. In that context, dictyostatin can be considered as a cyclic 
discodermolide derivative.  The total synthesis of dictyostatin was reported concurrently by the 
Paterson61 and Curran62 groups in 2004.  Further studies with this marine product revealed that it 
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acts in a similar way to discodermolide, and that analogs of dictyostatin and discodermolide  
have a similar SAR.63   
 
 
Figure 11- The Marine Natural Product Dictyostatin 
 
The most important analogue of dictyostatin that can be applied to the discodermolide 
SAR is saturation of the terminal double bond at C25-2664 (the dictyostatin backbone is 2 
carbons longer than discodermolide, so this would correspond to C23-24 of discodermolide). 
Other changes to the dictyostatin backbone that are beneficial for its biological activity include 
epimerization of the C6 methyl group,65 and removal of the C16 methyl group.66  These changes 
concur with the SAR that emerged through the synthesis of discodermolide analogs. 
1.5.5 Hybrid Microtubule Stabilizer Analogs  
The unique biological properties of discodermolide compared to other microtubule stabilizers 
and the potential overlap in the taxane binding pocket37,50 led to the pursuit of hybrid molecules 
of this class.  Hybrids of discodermolide and dictyostatin were first made by cyclizing 
discodermolide with simple alkyl chains to result in a macrolide like dictyostatin.67  These 
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analogs showed much lower potency than discodermolide and dictyostatin.  In another hybrid 
designed by Paterson,  the C2-C24 backbone of discodermolide and the Z-enolate of dictyostatin 
were used, but the analogue showed lower activity than discodermolide.68  Paterson also reported 
a hybrid where the C6-C24 fragment of discodermolide was coupled with the C1-C7 fragment of 
dictyostatin, which showed activity intermediate to that of the two individual natural products.69  
Paterson describes the synthesis of a paclitaxel-discodermolide-dictyostatin analogue.  In this 
work, the C6-C24 backbone of discodermolide was connected to the C1-C7 fragment of 
dictyostatin, and the side chains of either paclitaxel and docetaxel were attached to either of the 
hydroxy groups (18, 19, Figure 12).70   These analogs were about five times less active than the 
natural products.  Smith and Horwitz recently prepared and tested discodermolide/paclitaxel 
hybrid molecules. These molecules paired the discodermolide base structure with aromatic 
groups similar to the chain of paclitaxel added to the carbamate position of the molecule.  The 
hybrids performed better than parent discodermolide in anti-proliferative assays against A549 
lung carcinoma cells and MCF-7 breast carcinoma cells.71  Construction of hybrid derivatives 
represents the most recent approach to the investigation of the discodermolide and dictyostatin 
SAR. 
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Figure 12- Paterson Discodermolide/Dictyostatin/Paclitaxel Hybrids containing the C8-C24 portion 
of Discodermolide, C1-C7 portion of Dictyostatin, and the side chains of Paclitaxel or Docetaxel 
 
1.6 GOALS OF STUDY 
Although there is much research on attempting to make discodermolide into a promising drug, I 
saw a lack of exploration into the SAR of the linker region of discodermolide.  The long term 
goals of this project are to design and synthesize simplified versions of discodermolide that have 
new middle fragments.  If analogs retain the hairpin conformation of the parent natural product 
then the compounds will retain potency.  Simplifying the discodermolide structure will also 
reduce the total number of steps needed to complete an active molecule.  Such simplified 
molecules that are devoid of pneumotoxicity but retain the potency and biological characteristics 
of discodermolide are quite attractive as potential drugs. 
To achieve these long term goals, I designed simple discodermolide analogs containing 
an olefin linkage and optimized a synthetic scheme to synthesize a few simple analogs.  I 
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designed virtual analogs, and screened them in a hologram quantitative structure-activity 
relationship (HQSAR).  These analogs are predicted to have activity in cell-based screens at 
levels near the activity of discodermolide.  Also, I worked toward synthesizing two carbamate 
and three lactone fragments derived from the SAR of discodermolide.   Some fragments were 
coupled together using olefin cross metathesis (Figure 13), resulting in the synthesis of 
simplified analogs ready for testing in both protein and cell-based screens 
.
 
Figure 13- Experimental Design for Discodermolide Analogs using Simple Linker Groups 
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2.0  MOLECULAR MODELING OF NEW DISCODERMOLIDE ANALOGS 
2.1 INTRODUCTION 
As documented in section 1.4, discodermolide keeps the same hairpin conformation in a variety 
of solvents.42,43,45  However, the structure of discodermolide bound in the taxane site of the β-
tubulin subunit of microtubules has not yet been elucidated, leaving ambiguity on what key 
residues interact with discodermolide. The high resolution cryo-electron microscopy structure of 
paclitaxel bound to β-tubulin72 has yet to be helpful in modeling the binding of discodermolide 
analogs in the taxane binding site.  So we looked to QSAR methods to predict the activity of 
novel analogs. 
Quantitative structure-activity relationship (QSAR) analysis is a process in which 
numerical predictions of activity can be obtained by using the structures and activities of analogs 
that have already been tested.  Salum and colleagues73 built an HQSAR (hologram quantitative 
structure-activity relationship) for analogs of discodermolide to predict activity of new 
discodermolide analogs.  This fragment-based approach used the activity of discodermolide and 
46 analogs in A549 non-small cell lung carcinoma cells to generate a predictive model.  They 
hypothesized that the C19 carbamate, C14 methyl, C11 hydroxyl, C7 hydroxyl and C1 carbonyl 
group of the lactone all should make important contacts in the binding site because they are 
repeatedly found in analogs that have excellent activity.     
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The modeling portion of my work has two parts.  The first part involves the design of 
analogs and the identification of their low energy conformations via molecular mechanics 
minimization. Here we are looking for new analogs that mimic the hairpin conformation well.  
The second part involves the prediction of activities for designed analogs using the HQSAR 
model for discodermolide analogs created by Salum and Andricopulo.  
2.2 RESULTS 
Sixteen new discodermolide analogs were assembled by taking one carbamate fragment and one 
lactone fragment to form a virtual analogue via an olefin linkage (Figure 14). The four possible 
carbamate fragments are identified by Arabic numerals 1-4 and the four lactone fragments are 
identified by letters A-D in Table 1. In the lab, such analogs could be made by performing a 
cross metathesis reaction using terminal alkenes of the two fragments.  For example, coupling of 
lactone B with carbamate 2 would yield analogue B-2 shown in Figure 14B.  The designed 
analogs then underwent energy minimization by molecular mechanics models using the Tripos 
forcefield.   
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Figure 14- Assembly of Analogs for HQSAR Screening 
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Table 1-Fragments Used for HQSAR Studies 
Lactone Fragment Carbamate Fragment 
 
 
A  
1 
 
 
B  
2 
 
 
 
C 
 
3 
 
D 
 
4 
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The energy minimized virtual analogs were then screened in silico for predicted activity 
with the HQSAR method designed by Salum and colleagues.73  Four different HQSAR models 
were used to evaluate the compounds using various parameters (Table 2).  For the HQSAR, six 
parameters are available to comprise a testing model.  They are atoms (A) that occur in the 
molecule, they types of bonds (B) connecting the different atoms in the molecule, and 
connections (C), meaning how the atoms are connected to one another.  Additionally, hydrogen 
atoms (H) found in the atom, the chirality (Ch) of individual positions and the donor or acceptor 
ability (DA) of atoms are also considered.  In principle, any combination of parameters can be 
used to form a model, and different combinations may result in a different predicted potency 
values.   In the first HQSAR model (model 1) atoms, bonds and connections were used.  In 
model 2, the same three parameters, plus hydrogen atoms and chirality were used.  In model 3, 
all six parameters mentioned above were used, whereas in model 4 atoms, connections and 
donor/acceptor ability were only used (Table 2).  
 
Table 2-HQSAR Model Parameters 
 
Parameters 
Statistical Parameters 
q
2
LOO r
2
 SEE HL N Size 
1. A/B/C 0.59 0.74 0.49 61 4 4-7 
2. A/B/C/H/Ch 0.64 0.88 0.33 199 5 6-9 
3. A/B/C/H/Ch/DA 0.59 0.89 0.32 151 6 4-7 
4. A/C/DA 0.58 0.81 0.43 61 5 4-7 
q2LOO-leave-on-out cross-validated correlation coefficient; r
2-non-cross-validated correlation coefficient; SEE-standard 
error of estimate; HL-hologram length; N-optimal number of components, Size-range of number of components used to build 
holograms. Parameters: A-atoms, B-bonds, C-connections, H-hydrogen atoms, Ch-chirality, DA-donor and acceptor 
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The methodology behind this HQSAR study involves breaking down a test set of virtual 
analogs into molecular fragments.  These molecular fragments can then be comparatively 
screened against the fragments found in the training set, which consist of discodermolide and the 
46 analogs disclosed by the Smith group with IC50 values against A549 lung carcinoma cell 
types.  The 16 virtual analogs that resulted from the combination of the fragments shown in 
Table 1 were screened in the HQSAR method of Salum to obtain predicted IC50 values.  These 
pIC50 (pIC50= -log[IC50 value in A549 cells]) and the percent fragments missing for analogs are 
shown in Tables 3 and 4.  In Tables 3 and 4, virtual analogs are identified by two characters 
representing the lactone and carbamate fragment that were combined to form a new analogue.  
Percent fragments missing are the percentage of virtual fragments found in the test molecule that 
do not occur in the training set of analogs.  These values were extrapolated for the final 
calculations of pIC50.  IC50 values correspond to the predicted micromolar concentration of these 
analogs for 50 % inhibition of A549 lung carcinoma cells.  Table 3 shows the values for models 
1 and 2 from Table 2.  Table 4 shows the values from models 3 and 4 from Table 2.  Active 
molecules will have high pIC50 values and low IC50 values. 
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Table 3-HQSAR pIC50 predictions, Models 1 and 2 
  Model 1   Model 2  
Compound 
Name 
pIC50 
value 
% Missing 
Fragments 
IC50 Value 
(µM) 
pIC50 
value 
% Missing 
Fragments 
IC50 Value 
(µM) 
A-1 7.0 5 0.100 6.6 9 0.251 
B-1 7.4 1 0.040 6.6 2 0.251 
C-1 7.9 1 0.013 7.2 2 0.063 
D-1 6.6 50 0.251 5.5 21 3.162 
A-2 7.4 0 0.040 5.2 6 6.310 
B-2 7.4 1 0.040 6.2 6 0.631 
C-2 7.9 1 0.013 6.8 7 0.159 
D-2 6.6 50 0.251 5.1 20 7.943 
A-3 6.3 4 0.501 5.8 8 1.585 
B-3 6.6 0 0.251 5.7 1 1.995 
C-3 7.1 0 0.079 6.3 1 0.501 
D-3 6.2 49 0.631 4.9 19 12.59 
A-4 6.9 0 0.126 6.1 2 0.794 
B-4 7.0 0 0.100 6.5 2 0.316 
C-4 7.5 0 0.032 7.1 2 0.079 
D-4 6.5 53 0.316 5.6 23 2.512 
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Table 4-HQSAR Results, Models 3 and 4 
  Model 3   Model 4  
Compound 
Name 
pIC50 
value 
% Missing 
Fragments 
IC50 value 
(µM) 
pIC50 
Value 
% Missing 
Fragments 
IC50 Value 
(µM) 
A-1 8.1 3 0.008 7.0 4 0.100 
B-1 7.5 1 0.032 7.4 1 0.040 
C-1 7.7 1 0.020 7.3 1 0.050 
D-1 6.3 17 0.501 5.4 12 3.981 
A-2 7.0 1 0.100 6.7 1 0.200 
B-2 7.1 2 0.079 7.1 1 0.079 
C-2 7.4 2 0.040 7.0 1 0.100 
D-2 6.0 17 1.000 5.1 12 7.943 
A-3 7.1 2 0.079 6.2 3 0.631 
B-3 6.5 0 0.316 6.6 0 0.251 
C-3 6.7 0 0.200 6.6 0 0.251 
D-3 5.2 17 6.310 4.5 11 31.62 
A-4 6.2 1 0.631 6.4 0 0.398 
B-4 6.3 1 0.501 6.8 0 0.159 
C-4 6.6 1 0.251 6.8 0 0.159 
D-4 5.1 19 7.943 4.9 12 12.59 
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The data generated by all four HQSAR models show that many of the proposed virtual 
analogs have high pIC50 values.  Out of sixteen analogs screened, one (C-1) has a predicted pIC50 
above 7.0 in all four models.  Four analogs (A-1, B-1, B-2 and C-2) have a predicted pIC50 value 
above 7.0 in three out of four models.  Five analogs (A-2, A-3, B-4, C-3 and C-4) have a 
predicted pIC50 value above 7.0 in at least one out of four models.  A pIC50 value of 7.0 
corresponds to an IC50 value of 100 nM, so analogs with a pIC50 in that range are potentially 
active anti-proliferative agents against A549 lung carcinoma cells.   
The structures of the four analogs that have a pIC50 value greater than 7.0 in three out of 
the four models are shown in Figure 15.  Two of the analogs (A-1 and B-1) contain the complete 
carbamate fragment, while the other two (B-2 and C-2) are saturated at the C23-24 position.  
Three different lactone portions (A, B and C) are represented, with only the coumarin lactone 
replacement (D) not appearing in this set of analogs. 
 
Figure 15- Virtual Analogs the have a pIC50 value above 7.0 in 3 out of 4 models 
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Analogue C-1 (Figure 16A) is the virtual compound that scores above 7.0 in all models.  
It consists of butyrolactone fragment C (Table 1) coupled to the complete C14-C24 carbamate 
fragment 1 (Table 1).  Considering the comparative way the HQSAR method works, it is not 
surprising that this particular virtual analogue scores well in all four HQSAR models.  Even 
without the complete middle fragment of discodermolide, both sides of this virtual molecule 
mimic portions of discodermolide found in analogs that are very potent in biological assays.  The 
energy minimization of C-1 shows that it can mimic the hairpin conformation of discodermolide 
to a great degree (Figure 16B). 
 
 
Figure 16- A. Analogue C-1 Structure. B. C-1 Overlaid on the 3-D structure of Discodermolide to 
Demonstrate the Hairpin Conformation of the Analogue  
 
Virtual analogs containing the coumarin moiety consistently had much lower pIC50 
values. A discodermolide analogue with coumarin in place of the naturally occurring lactone has 
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been synthesized and its biological activity has been disclosed by Smith.55 Unfortunately, this 
compound was never tested against the A549 lung carcinoma cell line, so it is not in the training 
set of 46 compounds that provide biological data for the IC50 predictions of the HQSAR 
model(s).  The absence of a coumarin moiety in the training set for the HQSAR can be seen by 
the high percent missing fragments value for all coumarin virtual analogs.  A high percentage of 
missing fragments means that the pIC50 value was extrapolated from the data.  Therefore, we can 
attribute the low pIC50 values of the coumarin fragment to its lack of inclusion in the training set.  
This means that although the model predicts low activity, the coumarin analogs may still be 
active compounds. 
2.3 CONCLUSION 
New virtual analogs of discodermolide were screened in a HQSAR experiment for predicted IC50 
values, using four different parameter model sets.  A high percentage of the virtual analogs are 
predicted to have a high pIC50 values.  One analogue (C-1) displays pIC50 value greater than 7 in 
all four model systems, while four more analogs (A-1, B-1, B-2, C-1) display pIC50 values 
greater than 7 in three out of the four model systems.  Another four analogs resulted in a pIC50 
value greater than 7 in at least one of the model systems.  These predictions are encouraging 
results for the use of an alkene linker as a substitute for the natural compound linker region.   
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3.0   SYNTHESIS OF SIMPLIFIED DISCODERMOLIDE FRAGMENTS 
3.1 INTRODUCTION 
The synthetic strategy used here is related to those developed in the Day group,74 Smith,8 and 
Novartis.75,76  Using the discodermolide SAR in chapters 1 and 2, target fragments were 
identified by activity of the regions and simplicity of synthesis.  Three fragments were selected 
as lactone groups 15, 22, and 23 along with two simplified carbamate fragments 20 and 24 
(Figure 17). The synthetic schemes for the fragments were designed to result in terminal olefins 
that could then be coupled together via olefin cross metathesis. 
A coumarin group 15, the phenol group 22, and the complete lactone from the natural 
product 23 with an allylic chain were chosen as lactone groups.  These groups were chosen based 
on the number of new steps needed to make the fragment.  Two carbamates were chosen for 
synthesis that retain three (20) or four (24) of the stereocenters found in the carbamate portion of 
discodermolide.  A benzene ring was used in place of the C20 methyl and C21-22 olefin for 
fragment 20.  This phenyl group could be an isostere to the terminal diene in biological studies.  
Carbamate fragment 24 contains the saturated C23-24.  Neither of these carbamate fragments 
contains either the C16 or C14 methyl groups found in discodermolide.   
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Figure 17- Fragments Targeted for Synthesis of Discodermolide Analogs 
 
3.2 RESULTS 
3.2.1  Synthesis of the Common Precursor 29   
The known common precursor 2974,75 for the fragments 23, and 24 was prepared as 
shown in Figure 18  by combining the routes of Day74 and Novartis.75  The synthesis of 29 starts 
with the reaction of Evans chiral oxazoladinone 25 (Figure 18) which was synthesized from (D)-
phenylalanine.77 Acylation of 25 with n-butyllithium (BuLi) and propionyl chloride78 gave the 
acyl-auxiliary 11 in 80%.  Enolization of  11 with dibutylboron triflate (Bu2BOTf) and 
diisopropylethyl amine (DIPEA) under typical Evans aldol condensation conditions79  followed 
by the addition of methacrolein gave the syn aldol adduct 26 along with a minor anti isomer in a 
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ratio of about 90/10.  Pure syn-isomer 26 was isolated in 66% yield by flash chromatography.  
An additional 6.3% of the anti-isomer was isolated.  The alcohol of 26 was protected with t-
butyldimethylsilyl triflate (TBSOTf) generating 27 in 87% yield as a white solid.  Without 
purification, 27 was hydroborated with 9-BBN in THF according to Novartis75 to give unstable 
intermediate 28.  Alcohol 28 was prone to spontaneous lactonization, so it was directly exposed 
to potassium t-butoxide to complete the conversion to 29.  This lactone was isolated in 55% 
yield.  The isolation of 29 as a single isomer shows that the hydroboration to give 28 was both 
regioselective (for the 1°-alcohol) and stereoselective (for the anti-isomer).  
 
 
Figure 18-Synthesis of the Common Precursor Lactone 29 
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3.2.2  Synthesis of the Simplified Carbamate Fragment 24 
The first attempt to make carbamate fragment 24 is shown in Figure 19.   Treatment of 29 with 
N,O-dimethylhydroxylamine and isopropylmagnesium chloride76 gave Weinreb amide 30. To 
minimize the chance for relactonization, crude 30 was immediately treated with sulfur trioxide-
pyridine (Parikh-Doehring oxidation8) to afford aldehyde 31 in 80% yield.  The Wittig reaction 
of aldehyde 3180 with propyltriphenylphosphonium bromide and BuLi was not reproducible. 
Alkene 32 was isolated in yields up to 61%, but typical yields were less than 25%. The 1H NMR 
spectrum of alkene 32 showed resonances at 5.2-5.6 ppm, but the E/Z ratio could not be 
determined due to overlapping of peaks.  The Z-isomer should be favored based on the 
methodology.81  Moving forward with limited amounts of 32, DIBAL-H reduction76 gave 
aldehyde 33 in 61%  yield. From this point, all intermediates are new compounds en route to 
discodermolide fragments.  Direct Grignard addition of 33 with 3-butenylmagnesium bromide82 
gave alcohol 34 in 43% yield.  A Felkin-Ahn analysis83 based on sterics suggested that the (R)-
isomer at C17 would be favored, and product 34 proved to be a ratio of 2/1 of inseparable 
isomers.  This was seen by the two NMR peaks at 3.61 and 3.62 ppm corresponding to a CH-O 
hydrogen shift. 
The mixture of alcohols 34 was protected with methoxymethyl chloride (MOMCl)84 to 
give 35 in 70% yield.  Desilylation of 35 with tetrabutylammoniumfluoride (TBAF)85 gave 
alcohol 36 in 48% isolated yield.  The final installation of the carbamate to give 24 was then 
abandoned due to the mounting problems with this route.  Specifically, the low yielding Wittig 
reaction and the inability to separate the diastereomeric Grignard products were significant 
detractions. 
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Figure 19- First Attempt for Simple Carbamate 24 
 
3.2.3 Redesigned Scheme for the Simple Carbamate Fragment 24 
The revised route to carbamate fragment 24 is shown in Figure 20.  In this route, the 
butenyl side chain and the Z-alkene are introduced in reverse order.  This should solve the yield 
problem with the Wittig reaction because the new aldehyde partner 42-syn has only one carbonyl 
group (unlike 31, which has two).  Additionally, all compounds in this reaction sequence are new 
except for Weinreb amide 37 and aldehyde 38. 
The common precursor 29 was again converted to the Weinreb amide 30.  Attempts to 
protect the primary alcohol of 30 with para-methoxybenzyl (PMB) and tert-butyldimethylsilyl 
(TBS) groups were not successful.  However, treatment of 30 with triethylsilyl chloride86 (TES-
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Cl), dimethylaminopyridine (DMAP) and imidazole gave the bis-silyl ether 37 in 59% yield 
along with 31% of lactone 29.   
The Weinreb amide 37 was reduced with DIBAL-H74 to form aldehyde 38 in 86% yield.  
Reaction of crude aldehyde 38 with 3-butenylmagnesium bromide led to olefin 39 in 70 % yield 
with a d.r. of 2:1 in favor of the target isomer 39-syn as assigned by 1H NMR spectroscopy.  For 
example, the protons on the carbinol carbon of 39-syn and 39-anti were observed at 3.84 and 
3.89 ppm.  The major isomer was assigned as syn by Felkin-Ahn model analysis.83  Separation 
by flash chromatography gave 40% yield of pure 39-syn with an additional 30% of a syn/anti 
mixture.  Alcohol 39-syn was protected with MOMCl84 to provide the triether 40 in 43% yield. 
Selective desilylation of triether 40 with acetic acid formed 1˚-alcohol 41 in 48% yield.   
This was oxidized under Parikh-Doering conditions to yield aldehyde 42.  The crude aldehyde 42 
was treated with the ylide derived from triphenylpropylphosphonium bromide and nBuLi to 
afford diene 35-syn in 70% with a Z/E ratio of 5:1 as determined by integration of peaks of the 
methylene hydrogen in the 2.4-3.0 ppm range in the 1H NMR spectrum.  These conditions are 
known to be Z-selective, so the major isomer was assigned as Z.81 
The diene 35-syn was treated with TBAF85 to result in alcohol 36-syn in 11% yield.  The 
resonances in the 1H and 13C NMR spectra of 35-syn and 36-syn matched one of the two sets of 
resonances in the spectra of the syn/anti mixtures of 35 and 36-syn in Scheme 20. The other set 
was absent, so 17-syn and 18-syn are isomerically pure.  Installation of the carbamate by the 
Kocovsky protocol87 with trichloroacetoisocyanate in dichloromethane resulted in 24 in 11% 
yield.  The route to 24 in Figure 20 has two more steps than the route in Figure 19, but it is 
better because the Wittig reaction occurred in much higher yield and because the needed syn-
isomer could be separated after the Grignard reaction. 
 41 
 
 
Figure 20- Revised Route to Carbamate Fragment 24 
 
3.2.4 Synthesis of the Phenyl Replacement Carbamate Fragment 20 
The synthesis of a second carbamate fragment 5 is shown in Figure 21.  This fragment is 
simplified with respect to 24; the tail of discodermolide (C20 and its methyl group and the C21-
22 alkene and its ethyl group) was replaced by a roughly isosteric phenyl group.  This 
simplification makes 20 easier to synthesize. Surprisingly, this simple fragment has never been 
synthesized before this study. 
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The synthesis of 20 started with preparation of aldehyde 47 by a similar route to the 
synthesis of fragment 24. An Evans aldol reaction75 of chiral auxiliary 11 and benzaldehyde 43 
gave alcohol 44 in 65% yield as a single diastereomer.  The alcohol 44 was protected with 
TBSOTf to result in ether 45 in 95% yield.  The chiral auxiliary was removed with lithium 
borohydride10 to give 62% yield of alcohol 46.  Finally, alcohol 46 was oxidzed8 with sulfur 
trioxide-pyridine to yield crude aldehyde 47 quantitatively. 
Direct Grignard reaction82 of crude aldehyde 47 with 3-butenylmagnesium bromide gave 
the new alcohol 48 as a mixture of diastereomers in 64% yield over two steps.  The desired 
diastereomer 48-syn was favored in a ratio of 3.5:1 as determined by 1H NMR spectroscopy. 
peaks occurring at 3.80 and 3.71 ppm.  These diastereomers could not be separated by either 
flash chromatography or chiral supercritical fluid chromatography; however, the needed isomer 
predominates according to Felkin-Ahn steric arguments,83 so we proceeded with the mixture. 
Alcohol 48 was protected with MOM-Cl, resulting in diether 49 in 74% yield.84  This 
diether was treated with TBAF85 to give alcohol 50 in 63% yield.  Finally, the carbamate group 
was installed by the Kocovsky protocol,87 resulting in carbamate fragment 20 in 52% yield.  
Unfortunately, the diastereomers were not separable at any point, so the final sample of 20 was 
about a 3.5/1 ratio of syn/anti isomers.  The route to 5 has only eight steps, compared to the 15 
steps needed to make 24 from the acyl-auxiliary.  If the phenyl group is an active structural 
modification, then this would be a useful simplification in the synthesis of discodermolide 
analogs. 
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Figure 21- Synthesis of Simple Carbamate Fragment 20 Containing a Phenyl End Group 
 
3.2.5 Synthesis of Courmarin Lactone 15 
A coumarin lactone fragment with a terminal olefin was made in four steps from 7-
methylcoumarin 51 (Figure 22).  7-Methylcoumarin 51 was brominated with N-
bromosuccinamide (NBS) to yield 52 as prepared by my colleague Ms. Amy Short.  7-Bromo-
methylcoumarin 52 was hydrolyzed to yield alcohol 53 quantitatively.  The primary alcohol 53 
was oxidized via Parikh-Doering conditions8 to result in aldehyde 54 in 66% yield.  
Methyltriphenylphosphonium bromide was treated with BuLi88and added to crude aldehyde 54 
to yield 15 in 16% yield.  This route was not optimized because enough material was obtained 
for coupling reactions.   
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Figure 22- Synthesis of the Coumarin Fragment 15 as a Lactone Replacement 
 
3.2.6 Synthesis of the Phenol Lactone Replacement 22 
Another lactone replacement group identified by the discodermolide SAR is a phenol group, so 
we targeted simple fragment 22.  The alcohol 55 was oxidized under Parikh-Doering conditions8 
to result in aldehyde 56 in 77% yield.  Crude aldehyde 56 underwent a Wittig coupling reaction80 
with the ylide of methyltriphenylphosphonium bromide to result in olefin 22 in 50% yield 
(Figure 23). 
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Figure 23- Synthesis of Phenol Fragment 22 as a Lactone Replacement 
3.2.7 Synthesis of Short-Chain Lactone 23 
A short chain lactone 23 which contains one less carbon and no C7 hydroxy groupp was also 
synthesized (Figure 24).  Aldehyde 31 was treated with titanium tetrachloride and 
allyltrimethylsilane.  The presumed alcohol intermediate was cyclized by trifluoracetic acid 
(TFA) treatment to yield 23 in 39% yield. Although Smith reports8 a d.r of 49:1, this reaction 
resulted in a 50/50 ratio of inseparable isomers.  This can be seen in the 1H NMR spectrum by 
the two triplets found at 2.56 ppm corresponding to the CH-O group at C5.  The lactone was 
used as a mixture in later coupling to the carbamate group.   
 
 
Figure 24- Synthesis of Short Chain Lactone Fragment 23 
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3.3 SUMMARY 
Five new fragments were synthesized for use in cross metathesis reactions.  The key steps for 
synthesis of simple fragments include aldol condensations using Evans’ oxazoladinone auxiliary 
to install two of the stereocenters found in the common precursor and a Grignard addition with 3-
butenylmagnesium bromide.  Lactone groups were prepared primarily with a Parikh-Doering 
oxidation followed by a Wittig addition with methyltriphenylphosphonium bromide. 
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4.0  SYNTHESIS OF DISCODERMOLIDE ANALOGS 
4.1 INTRODUCTION 
The fragments described in chapter 3 were designed to be coupled together using olefin cross 
metathesis.  An alkene linker is suggested to be a viable connector by the HQSAR studies found 
in chapter 2.  The possible advantages of an alkene linker compared to the full linker in 
discodermolide are 1) to remove three stereocenters found in the natural product; 2) to place both 
the lactone and carbamate fragments in a similar conformation as discodermolide; and 3) to use a 
robust synthetic method that cuts down on the total number of steps to complete chemical 
synthesis of analogs. 
Olefin metathesis has been used in the synthesis of natural products, including other 
microtubule stabilizers.89  A ring closing olefin metathesis approach was attempted for the C10-
C11 double bond by the Curran group,90  but other routes were more robust, and this route was 
not included in the total synthesis.  Hoveyda, Schrock and co-workers used a Z-selective ring-
closing metathesis in the synthesis of epothilone B.91  Recent examples have been seen using 
metathesis in the synthesis of the complex molecules such as tulearin C,92 and leiodermatolide.93 
Olefin cross metathesis was therefore used to prepare analogs of discodermolide that 
contain an alkene linker instead of the naturally occurring syn, anti-stereotriad.  The analogs 
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were made by coupling the three lactone groups with the phenyl replacement carbamate 20 that 
were discussed in chapter 3. 
4.2 RESULTS 
4.2.1 Final Steps of Analogue Synthesis 
Grubbs II ruthenium olefin metathesis catalyst was used to couple two fragments directly 
together to make simplified discodermolide analogs.  The short chain lactone 23 and carbamate 
20 were coupled with Grubbs II catalyst in methylene chloride by heating at reflux for 8 h to 
yield 13 mg of 57 in 24%  yield (Figure 25) as a complex mixture of inseparable isomers at the 
new alkene and the stereocenter containing a MOM ether.  Deprotection of analogue 57 was 
done by treatment with 4 M HCl overnight, yielding the mono-hydroxy product 58 in 60% yield 
(5.2 mg), as well as the di-alcohol product 59 in 54% (4.2 mg).  Analysis of the 1H NMR 
spectrum of 58 shows a mixture of E/Z isomers.  The ratio is unclear due to overlapping peaks in 
the 5.4-5.6 ppm range, but the E isomer is generally favored in cross metathesis reaction.94   The 
complete syntheses for the new analogs 58 and 59 only took 17 total steps, beginning with the 
aldol condensation using Evans chiral oxazoladinone auxiliary. 
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Figure 25- Analogue Containing Short Chain Lactone and Phenyl Carbamate Groups 
 
Synthesis of a new coumarin analogue is shown in Figure 26.  Coumarin 15 and phenyl 
carbamate 20 were heated to reflux in the presence of Grubbs II catalyst to yield 21 in 38% (16.6 
mg) as a mixture of isomers (Figure 26).  The ratio was again undetermined due to overlapping 
peaks in the 6.23-6.28 ppm region.  Alkene 21 was treated with 6 M HCl to yield 1.6 mg of 60 
(31%).   The complete synthesis of this analogue was completed in 14 total steps. 
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Figure 26- Synthesis of Analogue Containing Coumarin and Phenyl Carbamate Groups 
 
A third new analogue was prepared as shown in Figure 27.  Phenol lactone mimetic 22 
and phenyl carbamate fragment 20 (Figure 27) underwent olefin metathesis with Grubbs II 
catalyst to yield 61 in 33% yield (12 mg).  Again, the ratio of E/Z isomers was unclear by 1H 
NMR spectroscopy, but the presence of new alkene protons showed that the cross metathesis 
succeeded.  Alkene 61 was treated with 6 M HCl to yield 62 in 29% (1.5 mg).  The entire 
scheme to reach 62 took only 13 overall steps. 
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Figure 27- Synthesis of Analogue Containing Two Phenyl Groups 
 
In total, six compounds were made that will be used for testing in biological screening in 
breast cancer cell types.  The synthetic schemes used to make these compounds drastically limit 
the number of steps used to make the end product compared to the total synthesis of 
discodermolide.  The routes also were completed without any in-depth optimization.  Any 
analogue with potency as a microtubule stabilizer has potential for scale-up synthesis with 
optimization of the synthetic scheme.  Unfortunately, the cross metathesis method used for 
coupling was not stereoselective, and both cis and trans alkene isomers were apparent in product 
mixtures.  Although the cis-form of coupled product was desired in the initial design of the 
project, the trans-isomer may place the lactone and carbamate moieties in proper position, since 
carbamate 20 contains two rotatable methylenes, unlike the rigid backbone of discodermolide.  
Additionally, if the isomers are separated chromatographically, more compounds are available 
for biological testing. Unfortunately, purification of the isomers was not an easy task, and with 
only small amounts of compound, the analogs are not isomerically pure compounds.   
 
 52 
5.0  SUMMARY 
The goal of the project was to synthesis simplified analogs of discodermolide.  To achieve that 
end, I first designed 16 virtual analogs of discodermolide that contained a simple alkene linker.  
These analogs were screened in the HQSAR of Salum and Andricopulo for predicted activities 
using four different models.  One analogue (C-1) had pIC50 values above 7.0 in all four model 
sets, while four analogs (A-1, B-1, B-2 and C-2) had pIC50 values above 7.0 in three out of the 
four model sets.   
Three simple analogs of discodermolide were completed by total synthesis.  These 
analogs were made from the carbamate 20 and three simple lactones 15, 22, and 23.  The 
fragments were coupled together using olefin cross metathesis.  Unfortunately, the 
stereochemical isomers could not be separated, so they are reported here as isomeric mixtures.  
The total synthesis of these analogs took between 13 and 17 steps, much shorter than the total 
synthesis of discodermolide (usually 32 steps at minimum).  Optimization of the synthetic route 
and biological testing of the analogs can still be done to establish if these simple discodermolide 
analogs have potential as drugs. 
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6.0  EXPERIMENTAL SECTION 
Modeling Experimental 
General 
All simulations were done using SYBYL 8.0 platform run on Red Hat Enterprise Linux 
workstations.  Analogs were built using ChemDraw Ultra 12.0, and converted to correct .mol 
files on Chem 3D Pro 12.0.  PyMOL was used as viewing software for 3D rendering of analogs. 
HQSAR Predictions 
Discodermolide analogs were energy minimized employing the TRIPOS forcefield using 
10000 iterations in a gradient of 0.005 kcal/mol.  The previously developed HQSAR was used to 
predict the pIC50 (-log IC50; IC50 is the concentration of 50% inhibition of A549 lung carcinoma 
cells) of analogs of discodermolide.  A training set of 47 analogs was broken into fragments six 
to nine atoms in length, which were then differentiated according to the parameters of atoms, 
bonds, connectivity, chirality and hydrogen atoms.  These were then used for building molecular 
holograms and HQSAR models which identified positive atomic contributions to biological 
activity. Analogs were used as a test set, and evaluated with the same parameters, using the same 
process. 
 
 
Chemistry 
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General Information: All reactions were performed under an inert atmosphere of N2 gas in 
oven-dried glassware using anhydrous solvents unless stated otherwise.  Anhydrous THF was 
obtained from sodium/benzophenone distillation.  Anhydrous CH2Cl2 was obtained by 
distillation from CaH2.  All other anhydrous solvents were purchased from Sigma-Aldrich.  
Melting points for all compounds were obtained from a Fisher-Johns melting point apparatus.  
1H NMR spectra were obtained from a 600 MHz Bruker Ultrashield Plus spectrometer equipped 
with a cryoprobe.  13C NMR spectra were obtained in the same spectrometer at 150 MHz.  
Spectra were obtained using CDCl3 as solvent (unless stated otherwise) and reported relative to 
residual CHCl3 shift (7.26 ppm) for 
1H NMR spectra and CDCl3 (77.2 ppm) for 
13C NMR 
spectra.  Low-resolution mass spectra were obtained on an Applied Biosciences API 2000 ESI-
triple quadrupole mass spectrometer with a Shimadzu UFLC inlet system.  Gas chromatography 
was performed using a 5890 Series II Gas Chromatograph equipped with a Hewlett-Packard 
5971 Series Mass Selective Detector.   
 
D-Phenylalanol: D-Phenylalanine (10.0 g, 60.5 mmol) was added to a 500-mL 3-neck flask and 
dissolved in THF (30 mL).  A reflux condenser, an addition funnel and a septum were attached 
to the flask.  BF3•OEt2 (7.50 ml in ether, 60.5 mmol) was added dropwise to the flask by addition 
funnel, and after complete addition, the flask was heated at reflux for 2 h.  BH3•SMe2 (13.9 mL, 
5M in diethyl ether) was then added by slow dropwise addition (about 1 h) to the flask via the 
addition funnel.  The solution was then heated to reflux an additional 6 h.  The mixture was 
cooled overnight for 14 h, and then a 1:1 THF/EtOH (7.6 mL) mixture was added, followed by 
addition of 5 M NaOH solution (45 mL).  This mixture was refluxed for 12 h.  Upon cooling, the 
slurry was filtered, and the filtrate washed with THF (2 x 25 mL).  The organic phase was 
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evaporated, and the resulting slurry was extracted with CH2Cl2 (1 x 50 mL, 1 x 25 mL), dried 
with MgSO4, filtered, and concentrated in vacuo. The crude mixture was crystallized from hot 
ethyl acetate resulting in 4.77 g (52%) of white crystalline solid: m.p. 90-92 °C 1H NMR (600 
MHz, CDCl3) δ 7.31 (t, J = 10.8 Hz, 2 H), 7.23 (d, J = 10.8 Hz, 1 H), 7.19 (d, J = 10.2 Hz, 2 H), 
3.63 (dd, J = 15.9, 6 Hz, 1 H), 3.38 (dd, J = 16.2, 10.8 Hz, 1 H), 3.11 (m, 1 H), 2.79 (dd, J = 20.1 
Hz, 7.8 Hz, 1 H), 2.53 (dd, J = 20.1, 13.2 Hz, 1 H). 
 
4(R)-4-Phenylmethyl-2-oxazoladinone (25): The amino alcohol 25 (4.00 g, 26.5 mmol), diethyl 
carbonate (6.62 mL, 54.6 mmol) and potassium carbonate (0.366 g, 2.65 mmol) were all added 
to a small round bottom flask.  A distillation apparatus was attached, and the flask was lowered 
into a sand bath pre-heated to 135 °C for 3.5 h.  After cooling, workup for the reaction began 
with the addition of CH2Cl2 (25 mL). The contents of the reaction flask were added to a 
separatory funnel and the organic and aqueous phases were separated.  The organic portion was 
washed with water (25 mL), dried with MgSO4, filtered, and concentrated in vacuo.  
Recrystallization of the crude material in 2:1  hot hexane-ethyl acetate solvent resulted in 1.96 g 
(42%) of 25 as white crystals: m.p. 87.5-89 °C; 1H NMR (600 MHz, CDCl3) δ 7.34 (t, J = 7.2 
Hz, 2 H), 7.29 (t, J = 7.2 Hz, 1 H), 7.18 (d, J = 7.2 Hz, 2 H), 4.98 (br s, 1 H), 4.90 (t, J = 8.4 Hz, 
1 H), 4.16 (dd, J = 9.0, 5.4 Hz, 1 H), 4.09 (m, 1 H), 2.87 (qd, J = 13.5, 5.4 Hz, 2 H) 
 
3-(1-Oxopropyl)-4-(phenylmethyl)-(4R)-2-oxazolidinone (11): The auxiliary 25 (1.77 g, 10.0 
mmol) was dissolved in dry THF, placed under N2 gas, and cooled in an ice bath at 0 °C.  n-BuLi 
(6.88 mL, 11.0 mmol, 1.6 M in THF) was added dropwise to the solution.  This was followed by 
addition of propionyl chloride (1.04 ml, 12.0 mmol), and the solution was stirred overnight with 
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gradual warming to room temperature (about 14 h).  Workup proceeded with addition of 
saturated aq. NH4Cl (60 mL) and the solution was diluted with diethyl ether (60 mL).  The 
mixture was transferred to a separatory funnel. The layers were separated, and the organic 
fraction was washed with 1 M HCl (2 x 50 mL), 1 M NaOH (2 x 50 mL), and saturated aq. NaCl 
(50 mL).  The organic fraction was then dried with MgSO4, filtered, and concentrated in vacuo.  
Pure product 11 was isolated as a yellow gel by flash chromatography (5:1 hexane-ethyl acetate).  
Yellow crystals were obtained by placing product on vacuum with seed crystal resulting in 1.86 
g (80%): m.p. 41-46 °C, 1H NMR (600 MHz, CDCl3) δ 7.34 (t, J = 7.2 Hz, 2 H), 7.28 (t, J = 7.2 
Hz, 1 H), 7.21 (d, J = 7.2 Hz, 2 H), 4.67 (m, 1 H), 4.18 (m, 2 H), 3.30 (dd, J = 13.2, 3 Hz, 1 H), 
2.96 (m, 2 H), 2.76 (dd, J = 13.5, 9.6 Hz, 1 H), 1.20 (t, J = 7.2 Hz, 3 H) 
 
3-[(2R,3R)-3-Hydroxy-2,4-dimethyl-1-oxo-4-penten-1-yl]-4-(phenylmethyl)-(4R)-2-
oxazolidinone (26): The acyl-auxiliary 11 (2.00g, 8.57 mmol) was dissolved in dry CH2Cl2 (19 
mL), and cooled to 0 °C in an ice bath.  Dibutylboron triflate (10.28 mL, 10.28 mmol, 1 M in 
CH2Cl2) was added dropwise over 10 minutes to the solution, followed by the addition of DIPEA 
(1.94 mL, 11.1 mmol).  This solution was then cooled to -78 °C in an acetone/dry ice bath, and 
methacrolein (1.59 mL, 19.3 mmol) was added to the solution with slow addition over 20 
minutes.  The mixture was stirred for 20 min in the dry ice/acetone bath, warmed to 0 °C in an 
ice bath, and stirred an additional hour at this temperature.  After this time, pH 7 phosphate 
buffer was added (13.3 mL), followed by the addition of CH3OH (20 mL).  After 5 min of 
stirring, 30% H2O2 (13.3 mL) was added, followed by more CH3OH (26 mL).  This was stirred 
for 1 h. The reaction flask was then concentrated in vacuo, resulting in yellow slurry.  The slurry 
was transferred to a separatory funnel and was extracted with diethyl ether (2 x 25 mL).  The 
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organic layers were combined, washed with saturated aq. NaCl (2 x 25 mL), dried with MgSO4, 
filtered and concentrated in vacuo.  Purified product was isolated by flash chromatography (5:1 
hexane-ethyl acetate) resulting in 1.72 g (66%) product 26 as a clear gel:  1H NMR (600 MHz, 
CDCl3) δ 7.34 (t, J = 7.8 Hz, 2 H), 7.29 (t, J = 7.2 Hz, 1 H), 7.21 (d, J = 7.2 Hz, 2 H), 5.13 (s, 1 
H), 4.99 (s, 1 H), 4.71 (m, 1 H), 4.46 (s, 1 H), 4.21 (m, 2 H), 3.96 (qd, J = 7.2, 3 Hz, 1 H), 3.27 
(dd, J = 13.8, 3.6 Hz, 1 H), 2.96 (d, J = 3 Hz, 1 H), 2.80 (dd, J = 13.2, 9.6 Hz, 1 H), 1.74 (s, 3 H), 
1.19 (d, J = 6.6 Hz, 3 H) 
 
3-[(2R,3R)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-2,4-dimethyl-1-oxo-4-penten-1-yl]-4-
(phenylmethyl)-(4R)-2-oxazolidinone (27): The auxiliary starting material 26 (1.80 g, 5.93 
mmol) was placed in a round bottom flask, dissolved in CH2Cl2 (10 mL), placed in an 
atmosphere of N2 gas and cooled to 0 °C in an ice bath.  2,6-Lutidine (0.96 mL, 8.30 mmol) was 
added dropwise via syringe, followed by the dropwise addition of TBDMSOTf (1.50 mL, 6.52 
mmol).  This reaction mixture was stirred at 0 °C.  The reaction was monitored by TLC.  After 
1.5 h, the reaction was quenched with the addition of 20 mL of hexane and 10 mL of 1 M HCl.  
After transferring the contents of the reaction mixture to a separatory funnel, the aqueous layer 
was then extracted with hexane (2 x 10 mL).  The organic layers were then combined and 
washed with 1 M HCl (2 x 15 mL), saturated NaHCO3 (2 x 15 mL), and saturated NaCl (2 x 15 
mL).  The organic fraction was then dried with MgSO4, filtered and the solvent evaporated.  The 
result was a crude white solid 27 (1.65g, 82%) that was carried on without any purification: m.p. 
73-76 °C; 1H NMR (600 MHz, CDCl3) δ 7.33 (t, J = 7.2 Hz, 2 H), 7.29 (d, J = 4.2 Hz, 1 H), 7.21 
(d, J = 7.2 Hz, 2 H), 4.93 (s, 1 H), 4.983 (s, 1 H), 4.56 (m, 1 H), 4.34 (d, J = 6.0 Hz, 1 H), 4.15 
 58 
(m, 2 H), 4.0 (quin. J = 7.2 Hz, 1 H), 3.27 (dd, J = 13.2, 3 Hz, 1 H), 2.96, 2.75 (dd, J = 13.5, 10.2 
Hz, 1 H), 1.71 (s, 3 H), 1.20 (d, J = 7.2 Hz, 3 H), 0.90 (s, 9 H), 0.005 (s, 3 H) -0.02 (s, 3 H). 
 
3-[(2R,3R,4S)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-2,4-dimethyl-5-hydroxy-1-oxo-
pentan-1-yl]-4-(phenylmethyl)-(4R)-2-oxazolidinone (28): The TBDMS ether 27 (1.60 g, 3.83 
mmol) was dissolved in dry THF (15 mL), cooled to 0 °C in an ice bath, and put in an 
atmosphere of N2 gas.  9-BBN (15.3 mL, 0.5 M in THF) was then added dropwise. The solution 
was stirred for 15 min at 0 °C, and then for 5 h at room temperature.  EtOH-THF (1:1, 5.1 mL), 
pH 7 phosphate buffer (5.1 mL) and 30% hydrogen peroxide (5.1 mL) were added sequentially 
to the flask, which had been cooled to 0 °C.  The contents were stirred for 30 min at this 
temperature, then overnight at room temperature.  The reaction was quenched with the addition 
of 20% aq. NaHSO3 (40 mL) and heptanes (50 mL).  The layers were separated, and the aqueous 
layer was extracted with heptane (3 x 35 mL).  These organic layers were combined, and washed 
with saturated aq. NaCl (2 x 40 mL).  The organic fractions were then dried with MgSO4, filtered 
and concentrated in vacuo, resulting in 28.  It was carried forward without any further 
purification. 
 
(3R,4S,5S)-4-(tert-Butyldimethylsilanyloxy)-3,5-dimethyltetrahydropyran-2-one (29): The 
crude alcohol 28 (0.100 g, 0.23 mmol) was dissolved in dry THF (2.4 mL), placed in a round-
bottom flask under an atmosphere of N2 gas, and the flask was cooled to 0 °C in an ice bath.  
Potassium tert-butoxide (0.516 mg, 0.0046 mmol) was added to the flask, and the solution was 
allowed to stir for 1 h.  Workup proceeded with addition of hexane (10 mL).  The organic 
fraction was washed with saturated aq. NaCl (1 x 10 mL), dried with MgSO4, filtered, and 
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concentrated in vacuo. Crude product was then subjected to flash chromatography (SiO2; 9:1 
hexane-ethyl acetate) to yield the lactone 29 in 55% yield (59.4 mg):  m.p. 53-57 °C 1H NMR 
(600 MHz, CDCl3) δ 4.25 (t, J = 10.2, 1 H), 4.12 (dd, J = 10.8, 4.8 Hz, 1 H), 3.68 (br. t, J = 3 Hz, 
1 H), 2.62 (qd, J = 3.6 Hz, 7.5 Hz, 1 H), 2.20 (m, 1 H), 1.30 (d, J = 7.8 Hz, 3 H), 0.97 (d, J = 7.2 
Hz, 3 H), 0.90 (s, 9 H), 0.08 (d, J = 8.4 Hz, 6 H). 
 
 (2R,3S,4S)-3-(tert-Butyldimethylsilanyloxy)-5-hydroxy-2,4-dimethylpentanoic acid 
methyoxymethylamide (30): The δ-lactone 29 (1.10 g, 4.26 mmol) and methoxy methyl amide 
(0.644 g, 6.60 mmol) were placed in a round bottom flask, dissolved in dry THF (14 mL), placed 
in an atmosphere of N2 gas, and cooled to ~-15 °C in an acetone/dry ice bath.  i-PrMgCl (6.65 
mL, 13.3 mmol, 2M in THF) was added with dropwise addition via syringe, and the reaction was 
allowed to stir for 1 h and 20 min.  Workup began with addition of diethyl ether (12 mL), 
followed by 1:1 saturated aq. NH4Cl-water (24 mL).  The layers were separated, and the aqueous 
phase was extracted with diethyl ether (12 mL).  The organic layers were combined, washed with 
saturated aq. NaCl (3 x 15 mL), dried with MgSO4, filtered and evaporated, resulting in a clear 
oil 30, which was carried forward without any further purification: 1H NMR (600 MHz, CDCl3) 
δ 4.09 (dd J = 9.6 Hz, 3 Hz, 1 H), 3.73 (s, 3 H), 3.58 (m, 1 H), 3.25 (m, 1 H), 3.17 (br s, 3 H), 
3.12 (m, 1 H), 2.86 (m, 1 H), 1.91 (m, 1 H), 1.18 (d, J = 7.2 Hz, 3 H), 0.92 (s, 9 H), 0.11 (d, J = 
3.6 Hz, 6 H). 
 
(2R,3S,4S)-3-(tert-Butyldimethylsilanyloxy)-5-oxo-2,4-dimethylpentanoic acid 
methyoxymethylamide (31): The crude alcohol 30 (1.36 g, 4.26 mmol) was dissolved in dry 
CH2Cl2 (4.3 mL), placed in an atmosphere of N2 gas, and cooled to 0 °C in an ice bath.  Then, in 
 60 
succession, triethylamine (2.38 mL, 17.08 mmol), DMSO (1.51 mL), and SO3-pyridine (2.04 g, 
12.82 mmol) dissolved in DMSO (7.0 mL) were added to the flask.  The reaction was stirred for 
1.5 h.  Workup began with addition of diethyl ether (32 mL).  This was followed by addition of 1 
M NaHSO4 (16.4 mL) in water (4.6 mL).  This was stirred for 10 min on ice.  After this time, the 
layers were separated, and the aqueous phase was extracted with diethyl ether (30 mL).  The 
organic layers were combined, washed with 8% aq. NaHCO3 (30 mL) and saturated aq. NaCl (40 
mL).  The organic layer was then dried with MgSO4, filtered and evaporated resulting in a clear 
oil.  This was purified using flash chromatography (SiO2, 9:1 hexane-ethyl acetate) resulting in a 
clear oil 31 (80% over two steps): 1H NMR (600 MHz, CDCl3) δ 9.71 (s, 1 H), 4.25 (dd, J = 9.0, 
1.8 Hz, 1 H), 3.71 (s, 3 H), 3.13 (br s, 4 H), 2.47 (q, J = 5.4 Hz, 1 H), 1.28 (d, J = 7.8 Hz, 3 H), 
1.13 (d, J = 6.6 Hz, 3 H), 0.90 (s, 9 H), 0.12 (d, J = 3.6 Hz, 6 H). 
 
(2R,3S,4S,Z)-3-(tert-Butyldimethylsilanyloxy)-2,4-dimethyloct-5-enoic acid 
methyoxymethylamide (32): Propyltriphenylphosphonium bromide (1.22 g, 3.16 mmol) was 
dissolved in THF (7.4 mL), and cooled in an acetone-dry ice bath to –78 °C.  n-Butyl lithium 
(1.98 mL, 3.16 mmol, 1.6 M in THF) was added dropwise to the solution, and the reaction 
mixture was warmed to room temperature and stirred for 40 min.  During this time, the aldehyde 
31 (0.600 g, 1.89) was dissolved in THF (9.45 mL) and cooled in the dry ice/acetone bath.  The 
phosphonium ylide was transferred via syringe until the reaction mixture took on an orange 
color.  This was stirred at 0 °C for 1 h.  Workup was done with addition of saturated aq. NH4Cl 
(0.9 mL) and hexane (40 mL).  The layers were separated, and the organic layer was washed 
with water (2 x 15 mL) and saturated aq. NaCl (2 x 15 mL).  The organic layer was dried with 
MgSO4, filtered, and concentrated in vacuo.  Purification was done via flash chromatography 
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(SiO2, 9:1 hexane-ethyl acetate) resulting in 0.388 g (60%) of Wittig product as a clear oil 32: 
1H 
NMR (600 MHz, CDCl3) δ 5.46 (t, J = 10.2 Hz, 1 H), 5.35 (m, 1 H), 3.87 (d, J = 8.4 Hz, 1 H), 
3.64 (br s, 3 H), 3.13 (br s, 3 H), 2.90 (m, 1 H), 2.60 (m, 1 H), 1.99 (m, 1 H), 1.92 (m, 1 H), 1.11 
(d, J = 7.2, 3 H), 0.97 (d, J = 6.6 Hz), 0.91 (s, 9 H), 0.07 (d, J = 7.8 Hz, 6 H); 13C NMR (150 
MHz, CDCl3) δ 177.5, 132.2, 130.5, 61.4, 40.6, 36.5, 32.4, 26.4, 21.0, 19.6, 18.7, 15.8, 14.7, –
3.2; m/z (ESI) [M + H]+ 344.2. 
 
(2R,3S,4S,Z)-3-(tert-Butyldimethylsilanyloxy)-2,4-dimethyloct-5-enal (33):  The 
methoyxymethyl amide starting material 32 (0.345 g, 1.00 mmol) was dissolved in THF (1.02 
mL) and cooled in an acetone/dry ice bath to ~ –30 °C.  DIBAL-H (1.15 mL, 1 M in toluene) 
was added dropwise, and the mixture was stirred for 45 min.  CH3OH (0.5 mL) was added, 
followed by saturated aq. sodium potassium tartrate (12 mL) and hexane (12 mL).  The layers 
were separated, and the aqueous fraction was extracted with hexane (2 x 7 mL).  The organic 
layers were combined, washed with saturated aq. NaHCO3 (2 x 7 mL) and saturated aq. NaCl (2 
x 7 mL).  The organic layer was dried with MgSO4, filtered and concentrated in vacuo. The 
crude product was purified by flash chromatography (SiO2, 19:1 hexane-ethyl acetate) resulting 
in 0.175 g (61%) of clear oil 33: 1H NMR (600 MHz, CDCl3) δ 5.35 (m, 1 H), 5.30 (t, J = 10.2 
Hz, 1 H), 3.94 (t, J = 10.2 Hz, 1 H), 2.66 (m, 1 H), 2.47 (m, 1 H), 2.00 (m, 1 H), 1.95 (m, 1 H), 
1.06 (d, J = 6.6 Hz, 3 H), 0.99 (d, J = 6.6 Hz,  3 H), 0.90 (s, 12 H), 0.09 (s, 3 H), 0.05 (s, 3 H); 
13C (150 MHz, CDCl3), δ 204.66, 133.19, 129.92, 76.42, 51.75, 35.24, 25.78, 21.21, 19.14, 
14.16, 9.78, –4.03, –4.13. 
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(6S, 7S, 8S, Z)-7-((tert-Butyldimethylsilyl)oxy)-6,8-dimethyldodeca-1,9-dien-5-ol (34): 
Magnesium turnings (0.084 g, 3.47 mmol) and a crystal of I2 were placed in a round bottom 
flask.  4-Bromo-1-butene (0.32 ml, 3.15 mmol) was dissolved in anhydrous THF (3.15 ml), and 
added to the reaction flask slowly, allowing for the initiation of the reaction as evidenced by a 
color change from brown to grey.  The formation of the Grignard reagent was stirred for 1 h at 
room temperature.  In the meantime, aldehyde 33 (0.300g, 1.05 mmol) was dissolved in 
anhydrous THF (8.75 ml), and cooled to 0 °C in an ice bath.  The Grignard reagent was added 
via syrnige, and this reaction was stirred for 1.5 at 0 °C.  The reaction was quenched with the 
addition of saturated NH4Cl (5.3 ml).  The reaction mixture was then extracted with ethyl acetate 
(3 x 10 ml).  The organics were combined and washed with brine (10 ml).  The organics were 
then dried over Na2SO4, were filtered, and concentrated.  The crude mixture was purified by 
flash chromatography (SiO2, 0-100% ethyl acetate :hexane over 16 minutes) to yield 0.151 g 
(43%) of diastereomeric mixture of product 34: 1H NMR (600 MHz, CDCl3) δ 5.84-5.80 (m 1 
H), 5.54 (t, J = 10.7 Hz, 1 H), 5.47-5.41 (m, 1 H), 5.03 (d, J = 17.2 Hz, 1 H), 4.94 (d, J = 10.0 
Hz, 1 H), 3.79-3.68 (m, 1 H), 3.61 (s, 1 H), 2.75-2.69 (m, 1 H), 2.26-2.13 (m, 1 H), 2.13-1.98 (m, 
3 H), 1.94 (s, 1 H), 1.75-1.69 (m, 2 H), 1.41-1.30 (m, 1 H), 1.01-0.97 (m, 6 H), 0.97 (s, 12 H), 
0.07 (d, J = 12.3 Hz, 6 H); 13C NMR (150 MHz, CDCl3) δ 138.70, 132.46, 131.22, 114.55, 
78.93, 70.50, 42.42, 34.83, 34.76, 30.66, 26.04, 20.93, 19.34, 18.27, 14.27, 9.35, -4.03, -4.05; 
these resonances are the major peaks found in the 13C spectrum; m/z (ESI) [M – TBS + H]+ 
227.2. 
  
 (2R,3S,4S)-3-((tert-Butyldimethylsilyl)oxy)-N-methoxy-N,2,4-trimethyl-5-
((triethylsilyl)oxy)pentanamide (37): Weinreb’s amide 30 (2.891 g, 9.05 mmol) was dissolved 
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in anhydrous pyridine (161 ml).  N, N-dimethyl-4-aminopyridine (0.221 g, 1.81 mmol) was 
added to the reaction flask, followed by the addition of chlorotriethylsilane (3.2 ml, 19.01 
mmol).  The reaction was stirred overnight for 17.5 h.  Workup was done by dilution of the 
reaction mixture with methylene chloride (320 ml).  This was washed with a 1:1 mixture of 
saturated aqueous NaHCO3:H2O (160 ml).  The organics were dried over Na2SO4, were filtered 
and concentrated.  Purification of crude diether 37 was done by flash chromatography (SiO2, 
19:1 hexane: ethyl acetate), to yield 2.331 g of product (59%).  Additionally, 0.731 g of lactone 
29 (31%) was recovered from the reaction mixture: 1H NMR (600 MHz, CDCl3) δ 3.91 (dd, J = 
7.1, 3.8 Hz, 1 H), 3.74 (dd, J = 9.8, 4.5 Hz, 1 H), 3.69 (s, 3 H), 3.27 (t, J = 9.3 Hz, 1 H), 3.16 (s, 
3 H), 3.10 (m, 1 H), 1.76 (m, 1 H), 1.11 (d, J = 7.0 Hz, 3 H), 0.97 (d, J = 6.9 Hz, 3 H), 0.94 (t, J 
= 7.9 Hz, 9 H), 0.90 (s, 9 H), 0.57 (q, J = 8.0 Hz, 6 H), 0.05 (d, J = 12.1 Hz, 6 H); 13C NMR (150 
Hz, CDCl3) δ 75.46, 64.50, 61.19, 41.49, 38.90, 32.12, 32.12, 26.11, 18.33, 14.62, 14.31, 6.57, 
5.77, 4.34, -3.92, -4.02. 
 
(2R,3S,4S)-3-((tert-Butyldimethylsilyl)oxy)-2,4-dimethyl-5-((triethylsilyl)oxy)pentanal (38): 
Weinreb amide 37 (0.714 g, 1.65 mmol) was dissolved in anhydrous THF (12.5 ml) and cooled 
to -78 °C in an acetone/dry ice bath.  DiBAL-H (3.5 ml, 1M in toluene) was added drop-wise to 
the cooled solution, and the reaction was stirred for 6 h in the acetone/dry ice bath.  The reaction 
was quenched after this time with the addition of MeOH (2.5 ml).  Saturated aqueous sodium 
potassium tartrate (12.5 ml) and ethyl acetate (25 ml) were added to the reaction flask.  The flask 
was stirred an additional 2 h at room temperature.  After this, the layers were separated and the 
organic portion was washed with saturated aqueous NaHCO3 (50 ml) and brine (50 ml).  The 
organic portion was then dried over MgSO4, was filtered and concentrated, yielding 0.534 g 
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(86%) of crude aldehyde 38: 1H NMR (600 MHz, CDCl3) δ 9.72 (s, 1 H), 4.19 (dd, J = 6, 3.6 Hz 
1 H), 3.65 (dd, J = 9.6, 5.4 Hz, 1 H), 3.47 (dd, J = 10.2, 6 Hz, 1 H), 2.50 (qd, J = 7.2, 3.6 Hz 1 
H), 1.10 (d, J = 7.2 Hz, 3 H), 0.96 (t, J = 7.8 Hz, 9 H), 0.92 (d, J = 7.2 Hz, 3 H), 0.86 (s, 9 H), 
0.59 (q, J = 7.8 Hz, 6 H), 0.07 (s, 3 H), -0.01 (s, 3 H); 13C NMR (150 MHz, CDCl3) 205.14, 
72.17, 64.50, 50.00, 40.39, 25.90, 18.22, 13.84, 8.02, 6.80, 4.38, -4.18, -4.35. 
  
(5R,6S,7S,8S)-7-((tert-Butyldimethylsilyl)oxy)-6,8-dimethyl-9-((triethylsilyl)oxy)non-1-en-5-
ol (39): The Grignard reagent was prepared by placing magnesium turnings (0.634 g, 26.07 
mmol) in an oven-dried round bottom flask, along with a crystal of iodine.  4-Bromo-1-butene 
(2.4 ml, 23.70 mmol) was dissolved in anhydrous THF (23.7 mL) and added to the reaction flask 
slowly.  After complete addition, the reaction was deemed to have initiated by the change in 
color from brown to grey.  This flask was stirred for 1 h at room temperature.  The aldehyde 38 
(2.960 g, 7.90 mmol) was dissolved in anhydrous THF (66 mL) and cooled to 0 °C in an ice 
bath.  The Grignard reagent was added to this reaction flask, and stirred for 2 h.  The reaction 
was quenched with the addition of saturated aqueous NH4Cl (39.5 mL).  This mixture was then 
extracted with ethyl acetate (3 x 79 mL).  The organics were combined, and washed with brine 
(79 mL).  It was dried over Na2SO4, was filtered, and concentrated in vacuo.  The mixture was 
purified by flash chromatography (SiO2, 19:1 hexane: ethyl acetate), yielding the correct isomer 
of 39 (1.36 g, 40%).  Additionally, another 1.01 g of a mixture of both diastereomers was 
isolated (30% yield): 1H NMR (600 MHz, CDCl3) δ 5.85-5.81 (m, 1 H), 5.03 (d, J = 17.1 Hz, 1 
H), 4.95 (d, J = 10.1 Hz, 1 H), 3.83 (t, J = 4.0 Hz, 1 H), 3.72-3.70 (m, 1 H), 3.64 (dd, J = 7.9, 9.9 
Hz, 1 H), 3.43 (dd, J = 6.1, 10.0 Hz, 1 H), 2.66, (d, J = 3.1 Hz, 1 H), 2.26-2.20 (m, 1 H), 2.10-
2.05 (m, 1 H), 2.05-2.00 (m, 1 H), 1.72-1.70 (m, 1 H), 1.58-1.54 (m, 1 H), 1.49-1.43 (m, 1 H), 
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0.94 (t, J = 8.0, 9 H), 0.91 (d, J = 7.3 Hz, 3 H), 0.90 (s, 9 H), 0.88 (d, J = 7.1 Hz, 3 H), 0.59 (q, J 
= 8.0 Hz, 6 H), 0.07 (s, 6 H); 13C NMR (150 MHz, CDCl3) δ 138.81, 114.51, 76.30, 73.33, 
65.16, 40.54, 40.25, 34.18, 30.59, 26.01, 18.27, 14.02, 9.37, 6.78, 4.26, -3.78, -4.37; m/z (ESI) 
[M + H]+ 431.2. 
 
(5R,6S,7S,8S)-5-(But-3-en-1-yl)-7-((tert-butyldimethylsilyl)oxy)-11,11-diethyl-6,8-dimethyl-
2,4,10-trioxa-11-silatridecane (40): Alcohol 39 (1.362 g, 3.16 mmol) is dissolved in anhydrous 
toluene (3.0 mL).  Chloromethoxymethane (0.48 mL, 6.32 mmol) was added to the reaction 
flask, followed by addition of Hunig’s base (0.69 mL, 3.95 mmol).  The reaction was stirred for 
3 h at room temperature.  Work up was done by diluting the reaction with ethyl acetate (5.4 mL) 
and quenching the reaction with saturated aqueous NH4Cl (5.4 mL).  The layers were separated, 
and the aqueous phase was extracted with ethyl acetate (2 x 11 mL).  The organics were 
combined and washed with saturated aqueous NaHCO3 (2 x 11 mL) and brine (2 x 11 mL).  The 
organic phase was then dried over MgSO4, filtered and concentrated, resulting in a crude oil.  
This was purified via flash chromatography (SiO2, 19:1 hexane: ethyl acetate) resulting in 0.288 
g of 40 (19%).  Also isolated was 0.486 g of alcohol 41, a yield of 43% based on the amount of 
starting material 39.  1H NMR (600 MHz, CDCl3) δ 5.84-5.79 (m, 1 H), 5.03 (d, J = 17.1 Hz, 1 
H), 4.95 (d, J = 10.1 Hz, 1 H), 4.62 (q, J = 7.0 Hz, 2 H), 3.70 (t, J = 4.3 Hz, 1 H), 3.66 (dd, J = 
5.3, 9.8 Hz, 1 H), 3.49 (q, J = 5.8 Hz, 1 H), 3.38 (s, 3 H), 2.12-2.07 (m, 2 H), 1.90-1.88 (m, 1 H), 
1.83-1.80 (m, 1 H), 1.68-1.63 (m, 2 H), 0.95 (t, J = 8.0 Hz, 9 H), 0.91 (d, J = 7.0 Hz, 6 H), 0.89 
(s, 9 H), 0.58 (q, J = 8.0 Hz, 6 H), 0.05 (d, J = 4.5 Hz, 6 H); 13C NMR (150 MHz, CDCl3)  δ 
138.64, 114.51, 101.15, 96.38, 79.73, 73.80, 64.73, 55.79, 40.92, 38.73, 31.48, 29.43, 26.13, 
18.47, 14.30, 10.84, 6.82, 4.37, -3.77, -3.78; m/z (ESI) [M +H]+ 475.0. 
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(2S,3S,4S,5R)-3-((tert-Butyldimethylsilyl)oxy)-5-(methoxymethoxy)-2,4-dimethylnon-8-en-
1-ol (41): Triether 40 (0.288 g, 0.607 mmol) was dissolved in anhydrous THF (0.49 mL), and 
MeOH (0.49 mL).  The reaction was cooled to 0 °C by an ice bath, and H2O (0.15 mL) was 
added, followed by addition of acetic acid (52 µl, 0.91 mmol).  The reaction was stirred for 4 h in 
the ice bath.  After this, the reaction was diluted with H2O (2 mL) and was extracted with ethyl 
acetate (3 x 4 mL).  The organics were combined, and washed with saturated aqueous NaHCO3 
(2 x 2 mL) and H2O (2 x 2.4 mL).  The organics were dried over MgSO4, filtered and 
concentrated in vacuo.  The product was purified by flash chromatography (SiO2, 7:1 hexane: 
ethyl acetate), yielding 0.105 g of isolated alcohol 41 (48%): 1H NMR (600 MHz, CDCl3) δ 
5.83-5.79 (m, 1 H), 5.04 (d, J = 16.7 Hz, 1 H), 4.97 (d, J =  10.2 Hz, 1 H), 4.62 (dd, J = 17.5, 6.8 
Hz, 2 H), 3.82 (dd, J = 5.5, 3.5 Hz, 1 H), 3.69-3.66 (m, 1 H), 3.54-3.51 (m, 1 H), 3.39 (s, 3 H), 
2.62 (t, J = 6.0 Hz, 1 H), 2.13-2.06 (m, 2 H), 1.99-1.97 (m, 1 H), 1.95-1.91 (m, 1 H), 1.65 (q, J = 
6.9 Hz, 1 H), 0.98 (d, J = 7.1 Hz, 3 H), 0.95 (d, J = 7.0 Hz, 3 H), 0.92 (s, 9 H), 0.10 (d, J = 11.4 
Hz, 6 H); 13C NMR (150 MHz, CDCl3) δ 167.51, 138.28, 114.90, 79.52, 75.81, 65.22, 55.94, 
39.21, 38.91, 30.97, 30.08, 26.16, 18.38, 14.52, 11.56, -3.46, -3.91; m/z (ESI) [M + H]+ 361.3, 
[M + Na]+ 383.1. 
 
(2R,3R,4S,5R)-3-((tert-Butyldimethylsilyl)oxy)-5-(methoxymethoxy)-2,4-dimethylnon-8-enal 
(42): Alcohol 41 (0.591g, 1.64 mmol) was dissolved in anhydrous methylene chloride (4.1 mL) 
and DMSO (8.2 mL), and cooled to 0 °C in an ice bath.  Triethylamine (1.1 mL, 7.77 mmol) was 
added, followed by addition of sulfur trioxide-pyridine (0.968 g, 6.08 mmol).  The reaction was 
stirred for 1.5 h at 0 °C.  Work up was done by diluting the reaction with diethyl ether (21 mL).  
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The reaction mixture was then washed with H2O (16 mL) saturated aqueous NaHCO3 (16 mL) 
H2O (16 mL) again and brine (16 mL).  It was dried over MgSO4, was filtered and concentrated 
in vacuo, resulting in 0.532 g of crude 42.  No purification was done on this aldehyde:  1H NMR 
(600 MHz, CDCl3) δ 9.76 (s, 1 H), 5.81-5.78 (m, 1 H), 5.03 (d, J = 17.2 Hz, 1 H), 4.9 (d, J = 
10.2 Hz, 1 H) 4.59 (dd, J = 20.6, 6.8 Hz, 2 H), 3.96 (dd, J = 6.3, 3.4 Hz, 1 H), 3.55 (dd, J = 10.2, 
6.1 Hz, 1 H) 3.36 (s, 3 H) 2.70 (m 1 H), 2.08-2.05 (m, 2 H), 1.90-1.87 (m, 1 H), 1.70-1.63 (m, 2 
H), 1.11 (d, J = 7.0, 3 H), 0.97 (d, J = 7.0, 3 H), 0.88 (s, 9 H), 0.08 (d, J = 6.1 Hz, 6 H); 13C 
NMR (150 MHz, CDCl3) δ 204.66, 138.14, 114.94, 96.11, 78.54, 74.87, 55.84, 50.65, 40.23, 
31.12, 29.92, 29.79, 25.98, 18.31, 11.76, 11.77, -3.82 m/z (ESI) [M + H]+  359.1. 
 
(6S, 7S)-5-(But-3-en-1-yl)-7-((S,Z,)-hex-3-en-2-yl)-6,9,9,10,10-pentamethyl-2,4,8-trioxa-9-
silaundecane (35): Propyltriphenylphosphonium bromide (0.855 g, 2.22 mmol) was suspended 
in anhydrous THF (5.2 mL), and cooled to -78 °C in an acetone/dry ice bath.  nBuLi (1.4 mL, 
2.24 mmol, 1.6 M) was added, and the contents of the flask were stirred for 2 h at room 
temperature.  The aldehyde 42 (0.241 g, 0.673 mmol) was dissolved in anhydrous THF (3.4 mL).  
The phosphonium reagent was added to the aldehyde reaction flask cooled to 0 °C in an ice bath.  
This was stirred 18 h overnight, gradually warming to room temperature.  The reaction was 
quenched with the addition of saturated aqueous NH4Cl (1.4 mL), and then diluted with hexane 
(10 mL).  The reaction mixture was washed with H2O (2 x 10 mL) and brine (2 x 10 mL).  The 
aqueous portions were combined, and extracted once more with hexane (10 mL).  The organics 
were combined, dried over MgSO4, were filtered and concentrated.  The crude mixture was 
purified by flash chromatography (SiO2, 19:1 hexane: ethyl acetate), yielding 0.182 g of 35 (70% 
yield):  1H NMR (600 MHz, CDCl3) δ 5.84-5.77 (m, 1 H), 5.39-5.34 (m, 2 H), 5.01 (d, J = 17.0 
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Hz, 1 H), 4.95 (d, J = 9.6 Hz, 1 H), 4.61 (dd, J = 30.3, 6.8 Hz, 2 H), 3.61 (dd, J = 5.8, 3.2 Hz, 1 
H), 3.48, (dd, J = 10.8, 6.0 Hz, 1 H), 3.39, (s, 3 H), 2.75-2.70 (m, 1 H), 2.08-1.99 (m, 4 H), 1.72-
1.69 (m, 1 H), 1.64-1.56 (m, 2 H), 0.99-0.96 (m, 6 H), 0.92 (s, 12 H), 0.07 (d, J = 3.4 Hz, 6 H); 
13C NMR (150 MHz, CDCl3) δ 138.53, 131.56, 131.00, 114.53, 95.98, 78.99, 76.03, 55.79, 
39.44, 36.19, 29.77, 26.22, 26.17, 20.98, 18.62, 18.50, 14.44, 10.97, -3.35, -3.60; m/z (ESI) [M – 
TBS - CH3 + Na]
+ 279.0 [M – CH3 + Na]
+ 393.3. 
 
(5S, 6S, 7R, Z)-8-(Methoxymethoxy)-5,7-dimethyldodeca-3,11-dien-6-ol (36): Diene 35 
(0.101g, 0.262 mmol) was dissolved in anhydrous THF (1.1 mL).  tetrabutylammoniumfluoride 
(TBAF, 0.87 mL, 1 M in THF).  The reaction was stirred for 3 days at room temperature.  The 
reaction was quenched with the addition of saturated aqueous NH4Cl (0.8 mL).  The mixture was 
extracted with diethyl ether (2 x 2 mL).  It was dried over MgSO4, filtered, and concentrated in 
vacuo.  The crude product was purified via flash chromatography (SiO2, 9:1 hexane: ethyl 
acetate) resulting in 7.6 mg of isolated product 36 (11% yield):  1 H NMR (600 MHz, CDCl3) δ 
5.85-5.80 (m, 1 H), 5.54-5.52 (m, 1 H), 5.23, (t, J = 10.2 Hz, 1 H), 5.03 (d, J = 17.0 Hz, 1 H), 
4.96 (d, J = 10.1 Hz, 1 H), 4.68 (dd, J = 31.2, 6.8 Hz, 2 H), 3.63 (dd, J = 11.2, 5.8 Hz, 1 H), 3.40, 
(s, 3 H), 2.66-2.60 (m, 1 H), 2.51 (s, 1 H), 2.12-2.06 (m, 4 H), 1.86-1.84 (m, 1 H), 1.76-1.74 (m, 
1 H), 1.66-1.66 (m, 1 H), 1.00-0.94 (m, 6 H), 0.91 (d, J = 6.7 Hz, 3 H); 13C (150 MHz, CDCl3) δ 
138.46, 133.49, 131.93, 114.67, 96.12, 81.58, 55.95, 53.48, 36.88, 35.63, 30.67, 29.66, 17.45, 
14.44, 7.59; m/z (ESI) [M + Na]+ 293.4, [M + K]+ 309.1. 
 
(5S,6S,7S,8R,Z)-8-(Methoxymethoxy)-5,7-dimethyldodeca-3,11-dien-6-yl carbamate (24): 
Diene 36 (31.4 mg, 0.116 mmol) was dissolved in anhydrous methylene chloride (0.24 mL).  
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Trichloroacetoisocyanate (14.5 µl, 0.122 mmol) was dissolved in anhydrous benzene (0.12 mL) 
and added to the reaction flask at room temperature.  The reaction was stirred for 3 h.  After this 
time, the reaction mixture was diluted with DCM (5 mL) and was poured over a bed of alumina 
(Al2O3), and left for 15 min.  The alumina was washed with DCM (25 mL, 10 mL) and hexane 
(10 mL).  The organics were then evaporated, resulting in 24 (4.0 mg) in 11%. 1 H NMR (600 
MHz, CDCl3) δ 5.84-5.75 (m, 1 H), 5.40-5.30 (m, 2 H), 5.01 (d, J = 17.1 Hz, 1 H), 4.95 (d, J = 
10.2 Hz, 1 H), 4.61-4.59 (m, 3 H), 3.62-3.61 (m, 1 H), 3.49 (q, J = 4.4 Hz, 1 H), 3.39 (s, 3 H), 
2.73-2.71 (m, 1 H), 2.09-1.96 (m, 4 H), 1.68-1.64 (m, 3 H), 1.63-1.59 (m, 3 H), 0.99-0.94 (m, 9 
H); m/z (ESI) [M + H]+ 314.3, [M + Na]+ 336.2. 
 
(R)-4-Benzyl-3-((2R,3R)-3-hydroxy-2-methyl-3-phenylpropanoyl)oxazolidin-2-one (44): 
Auxiliary 11 (6.02 g, 25.81 mmol) was dissolved in anhydrous methylene chloride (56.1mL), 
and cooled to 0 °C in an ice bath.  Dibutylboron triflate (31.0 mL, 31.0 mmol, 1M in DCM) was 
added to the reaction flask, followed by addition of Hunig’s base (5.8 mL, 33.55 mmol).  The 
reaction flask was moved to an acetone/dry ice bath cooled to -78 °C, and benzaldehyde 43 (5.9 
mL, 58.07 mmol) was added to the reaction flask.  This was stirred for 20 min at -78 °C, and for 
1 h at 0 °C.  At this time, pH 7 phosphate buffer (37.4 mL), MeOH (56.1 mL) and 30 % H2O2 in 
MeOH (37.4 mL in 84.2 mL) were added to the reaction flask, and it was stirred an additional 
hour at 0 °C.  After this, the reaction flask was concentrated.  The residue was extracted with 
diethyl ether (2 x 85 mL).  The organic portions were combined, and washed with brine (2 x 85 
mL).  The organics were then dried over MgSO4, were filtered and concentrated.  Purification 
was done by flash chromatography (SiO2, 9:1 hexane: ethyl acetate), yielding 5.30 g of product 
44 (61%): 1H NMR (600 MHz, CDCl3) δ 7.39 (d, J = 7.4 Hz, 2 H), 7.33 (q, J = 7.4 Hz, 4 H) 7.28 
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(q, J = 7.5 Hz, 2 H), 7.20 (d, J = 7.1 Hz, 2 H), 5.10 (d, J = 3.8 Hz, 1 H), 4.62-4.58 (m, 1 H), 
4.16-4.07 (m, 4 H), 3.24 (dd, J = 13.4, 3.2 Hz, 1 H), 3.09 (bs, 1 H), 2.77 (dd, J = 13.4 , 9.6 Hz, 1 
H), 1.17 (d, J = 7.0 Hz, 3 H); 13C NMR (150 MHz, CDCl3) δ 176.70, 152.88, 141.25, 135.00, 
129.40, 128.95, 128.23, 127.52, 127.41, 126.09, 73.80, 66.13, 55.21, 44.52, 37.74, 10.89; m/z 
(ESI) [M + H]+ 340.1, [M + Na]+ 362.1. 
  
(R)-4-Benzyl-3-((2R,3R)-3-((tert-butyldimethylsilyl)oxy)-2-methyl-3-
phenylpropanoyl)oxazolidin-2-one (45): Alcohol 44 (5.303 g, 15.63 mmol) was dissolved in 
anhydrous DCM (26.1 mL) and cooled to 0 °C in an ice bath.  2,6 Lutidine (2.5 mL, 21.88  
mmol) was added, followed by the addition of TBDMSOTf (4.0 mL, 17.19 mmol).  The reaction 
was stirred for 1.5 h at 0 °C.  Work up was done with the addition of 1 M HCl (26 mL) and 
hexane (52 mL).  The layers were separated, and the aqueous phase was extracted with hexane 
(52 mL).  The organics were combined, and washed with 1 M HCl (2 x 52 mL), saturated 
aqueous NaHCO3 (2 x 52 mL) and brine (52 mL). It was dried over MgSO4, was filtered and 
concentrated, resulting in 6.734 g of crude product 45 as a white solid (95%).  No purification 
was done on the crude product:  1H NMR (600 MHz, CDCl3) δ 7.35 (d, J = 7.2 Hz, 2 H), 7.31 (t, 
J = 7.2 Hz, 2 H), 7.27 (t, J = 7.2 Hz, 3 H), 7.21 (t, J = 7.2 Hz, 1 H), 7.17 (d, J = 7.2 Hz, 2 H), 
4.83 (d, J = 7.2 Hz, 1 H) 4.27-4.23 (m, 1H), 4.15 (p, J = 6.6 Hz, 1 H), 3.98 (dd, J = 9, 1.8 Hz, 1 
H), 3.68 (t, J = 8.4 Hz, 1 H), 3.20 (dd, J = 13.2, 3.6 Hz, 1 H), 2.69 (dd, J = 13.2, 9.6 Hz, 1 H), 
1.29 (d, J = 6.6 Hz, 3 H) 0.88 (s, 9 H), 0.01 (s, 3 H) -0.23 (s, 3 H); 13C NMR (150 MHz, CDCl3) 
δ 152.88, 142.85, 135.38, 129.42, 128.90, 127.86, 127.40, 127.28, 126.68, 104.43, 99.96, 96.39, 
76.57, 65.86, 55.73, 46.69, 37.69, 25.72, 18.10, 12.87, -4.68, -5.28; m/z (ESI) [M + Na] + 476.0 
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(2S,3R)-3-((tert-Butyldimethylsilyl)oxy)-2-methyl-3-phenylpropan-1-ol (46): Silyl ether 45 
(6.734 g, 14.84 mmol) was dissolved in anhydrous THF (118 mL), and cooled to -78 °C in an 
acetone/dry ice bath.  Ethanol (1.3 mL, 22.26 mmol) was added to the reaction flask, followed by 
the addition of lithium borohydride (11.1 mL, 2M in THF).  The reaction was stirred for 1 h at -
78 °C, and 16.5 h at room temperature.  After this time, diethyl ether (177 mL) and 1 M NaOH 
(59 mL) were added to the reaction flask, and the reaction was stirred for an additional 4 h.  The 
reaction was quenched with the addition of saturated aqueous NH4Cl (59 mL).  The layers were 
separated, and the aqueous portion was extracted with diethyl ether (3 x 120 mL).  The organics 
were combined, washed with brine (2 x 150 mL) and dried over Na2SO4.  It was filtered and 
concentrated.  The crude mixture was taken up in hot hexane: ethyl acetate (9:1) to crystalize the 
oxazoladinone auxiliary as a white solid (1.36 g, 52 % recovered).  The mother liquor was then 
purified by flash chromatography (SiO2, 9:1 hexane: ethyl acetate) to yield 2.59 g of alcohol 46 
62%.  An additional 0.266 g of auxiliary was isolated with flash chromatography, totaling in 62 
% recovery of auxiliary: 1H NMR (600 MHz, CDCl3) δ 7.33-7.26 (m, 4 H), 7.25 (t, J = 7.2 Hz, 1 
H), 4.83 (d, J = 4.2 Hz, 1 H), 3.60-3.56 (m, 1 H), 3.44 (p, J = 5.4 Hz, 1 H), 2.44 (t, J = 4.8 Hz, 1 
H), 2.09-2.04 (m, 1H) 0.91 (s, 9H), 0.77 (d, J = 7.2 Hz, 3 H), 0.05 (s, 3 H), -0.18 (s, 3 H); 13C 
NMR (150 MHz, CDCl3) δ 142.28, 127.81, 127.10, 126.75, 77.50, 65.51, 42.82, 25.80, 18.12, 
11.90, -4.69, -5.33; m/z (ESI) [M + H] 280.9. 
  
(2R,3R)-3-((tert-Butyldimethylsilyl)oxy)-2-methyl-3-phenylpropanal (47):  Alcohol 46 (2.58 
g, 9.20 mmol) was dissolved in anhydrous DCM (23 mL) and DMSO (46 mL), and cooled to 0 
°C in an ice bath.  Triethylamine (6.1 mL, 43.61 mmol) was added, followed by sulfur trioxide-
pyridine (5.43 g, 34.13 mmol).  The reaction was stirred for 1.5 h at 0 °C.  The reaction was 
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diluted with diethyl ether (115 mL).  The reaction mixture was washed with H2O (92 mL), 1 M 
NaHCO3 (92 mL), H2O (92 mL) and brine (92 mL).  It was dried over MgSO4, was filtered and 
concentrated, resulting in 2.758 g of crude aldehyde 47, which was used immediately in the next 
reaction step: 1H NMR (600 MHz, CDCl3) δ 9.76 (s, 1 H), 7.34-7.27 (m, 4 H), 7.26-7.25 (m, 1 
H), 5.15 (d, J = 4.3 Hz, 1 H), 2.61-2.56 (m, 1 H), 1.04 (d, J = 7.0 3 H), 0.89 (s, 9 H), 0.03 (s, 3 
H), -0,18 (s, 3 H). 
 
(1R,2S)-1-((tert-Butyldimethylsilyl)oxy)-2-methyl-1-phenylhept-6-en-3-ol (48): Magnesium 
turnings (0.738 g, 30.36 mmol) and a crystal of I2 were placed in a round bottom flask.  4-bromo-
1-butene (2.8 mL, 27.60 mmol) was dissolved in anhydrous THF (27. 6 mL).  This solution was 
added slowly to the flask containing turnings. The formation of the Grignard reagent was stirred 
for 1 h at room temperature.  In the meantime, Aldehyde 47 (2.562 g, 9.20 mmol) was dissolved 
in anhydrous THF (76.7 mL).  The Grignard reagent was added to the aldehyde solution cooled 
to 0 °C. The reaction was stirred an hour at 0 °C.  Work up was done by quenching the reaction 
with saturated NH4Cl (46 mL).  The mixture was extracted with EtOAc (3 x 93 mL).  The 
organics were combined and washed with brine (93 mL).  The organic portion was dried over 
Na2SO4, filtered and concentrated.  Purification was done by flash chromatography (SiO2, 19:1 
hexane: ethyl acetate), yielding 1.98 g (64 %) of both diastereomers 48 (3.5:1 Z/E):   1H NMR 
(600 MHz, CDCl3) δ 7.32-7.29 (m, 3 H), 7.27-7.26 (m, 1 H), 7.25-7.22 (m, 1 H), 5.83-5.78 (m, 1 
H), 5.00 (d, J = 17.1 Hz, 1 H), 4.94 (d, J = 11.2 Hz, 1 H), 4.81 (d, J = 4.7 Hz, 1 H), 3.74-3.70 (m, 
1 H), 2.34 (s, 1 H), 2.16-2.08 (m, 1 H), 2.06-2.00 (m, 1 H), 1.68-1.65 (m, 1 H), 1.45-1.42 (m, 1 
H), 0.91 (s, 9 H), 0.88 (d, J = 6.8 Hz, 3 H), 0.07 (s, 3 H), -0.27 (s, 3H); 13C NMR (150 MHz, 
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CDCl3) δ 143.58, 138.47, 127.91, 127.07, 126.41, 114.63, 79.45, 73.50, 45.29, 34.47, 30.39, 
25.85, 18.04, 6.47, -4.42, -5.20; m/z (ESI) [M + H]+ 335.2. 
  
(6S,7R)-5-(But-3-en-1-yl)-6,9,9,10,10-pentamethyl-7-phenyl-2,4,8-trioxa-9-silaundecane 
(49): Chloromethoxymethane (0.88 mL, 11.56 mmol) was added to a round bottom flask. 
Alcohol 48 (1.935 g, 5.78 mmol) was dissolved in anhydrous toluene (5.5 mL) and added to the 
reaction flask.  Hunig’s base (1.3 mL, 7.23 mmol) was added to the reaction flask, and the 
reaction was stirred for 3 hours at room temperature.  Work up was done by diluting the reaction 
mixture with ethyl acetate (8 mL), followed by quenching the reaction with saturated NH4Cl (8 
mL).  The layers were separated, and the aqueous was extracted with EtOAc (2 x 17 mL). The 
organics were combined, and washed with saturated aqueous NaHCO3 (2 x 17 mL) and brine (2 
x 17 mL).  The organics were dried over MgSO4, filtered and concentrated.  The residue was 
purified by flash chromatography (SiO2, 19:1 hexane: ethyl acetate) yielding 1.61 g of 49 (74 
%):  1H NMR (600 MHz, CDCl3) δ 7.32-7.28 (m, 4 H), 7.28-7.21 (m, 1 H), 5.70-5.61 (m, 1 H), 
4.90 (d, J = 18.8 Hz, 1 H), 4.85 (d, J = 10.1 Hz, 1 H), 4.60 (d, J = 7.3 Hz, 1 H), 4.58 (d, J = 6.8 
Hz, 1 H), 4.55 (d, J = 6.8 Hz, 1 H), 3.39 (s, 3 H), 3.18-3.16 (m, 1 H), 1.95-1.91 (m, 2 H), 1.84 
(td, J = 7.0, 3.3 Hz, 1 H), 1.68-1.64 (m, 1 H), 1.63-1.58 (m, 1 H), 1.05 (d, J = 6.9 Hz, 3 H), 0.85 
(s, 9 H), 0.02 (s, 3 H), -0.29 (s, 3 H); 13C NMR (150 MHz, CDCl3) δ 144.59, 138.22, 127.88, 
127.11, 126.55, 114.56, 96.88, 79.27, 76.43, 55.58, 44.89, 31.99, 29.84, 25.84, 18.13, 9.90, -
4.42, -4.96;  m/z (ESI) [M + H]+ 379.2, [M + K]+ 418.2 
 
(1R,2R)-3-(Methoxymethoxy)-2-methyl-1-phenylhept-6-en-1-ol (50): Diether 49 (0.387 g, 
1.02 mmol) was dissolved in anhydrous THF (4.1 mL) and cooled to 0 °C in an ice bath.  TBAF 
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(2.04 mL, 1M in THF) was added, and the reaction was stirred for 5 minutes at 0 °C, and 6 h at 
room temperature.  After this, the reaction was quenched with saturated NH4Cl (2.5 mL).  This 
mixture was extracted with diethyl ether (2 x 5 mL).  The organics were combined, and dried 
over MgSO4.  This was filtered off, and the solvent was concentrated.  Purification was done by 
flash chromatography (SiO2, 19:1 hexane: ethyl acetate) yielding 0.170 g of 50 (63 %): 
1H NMR 
(600 MHz, CDCl3) δ 7.35-7.33 (m, 4 H), 7.26-7.24 (m, 1 H), 5.81-5.76 (m, 1 H), 5.02 (d, J = 
17.1 Hz, 1 H), 4.97 (d, J = 10.4 Hz, 1 H), 4.94 (s, 1 H), 4.76 (d, J = 6.7 Hz, 1 H), 4.66 (d, J = 6.7 
Hz, 1 H), 3.79-3.77 (m, 1 H), 3.43 (s 3 H), 3.22 (s, 1 H), 2.05-2.03 (m, 2 H), 1.94-1.92 (m, 1 H), 
1.83-1.80 (m, 1 H), 1.64-1.61 (m, 1 H), 0.90 (d, J = 7.0 Hz, 3 H); 13C NMR (150 MHz, CDCl3) δ 
143.70, 137.87, 128.09, 126.94, 125.91, 114.98, 95.86, 81.63, 55.93, 42.36, 30.84, 29.89, 9.94, 
5.95;  m/z (ESI) [M + H]+ 265.2, [M + Na]+ 287.0. 
 
(1R,2S)-3-(Methoxymethoxy)-2-methyl-1-phenylhept-6-en-1-yl carbamate (20): Alcohol 50 
was dissolved in anhydrous DCM (1.3 mL). Trichloroacetoisocyanate (83 µl, 0.699 mmol) was 
dissolved in anhydrous benzene (0.7 mL) and added to the reaction flask.  The reaction was 
stirred for 1 h at room temperature.  After this, the reaction mixture was diluted with DCM (5 
mL) and poured over a pad of alumina.  After 5 minutes, the alumina was washed with DCM (25 
mL, 10 mL) and then the organics were concentrated in vacuo.  Purification was done by flash 
chromatography (SiO2, 3:1 hexane: ethyl acetate) yielding 0.119 g of 20 (52 %): 
1H NMR (600 
MHz, CDCl3) δ 7.35-7.30 (m, 4 H), 7.28-7.26 (m, 1 H), 5.74 (d, J = 7.3 Hz, 1 H), 5.73-5.70 (m, 1 
H), 4.95 (d, J = 17.0 Hz, 1 H), 4.90 (d, J = 10.1 Hz, 1 H), 4.66 (bs, 2 H), 4.60 (d, J = 6.8 hz, 1 
H), 4.51 (d, J = 6.9 hz, 1 H), 3.40 (s, 3 H), 3.26-2.24 (m, 1 H), 2.12 (td, J = 7.0, 3.4 Hz, 1 H), 
2.00 (q, J = 7.3 Hz, 2 H), 1.71-1.67 (m, 1 H), 1.64-1.59 (m, 1 H), 1.03 (d, J = 6.8 Hz, 3 H); 13C 
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NMR (150 MHz, CDCl3) δ 156.14, 138.08, 128.35, 126.92, 114.82, 101.16, 98.77, 96.78, 78.96, 
77.81, 55.75, 41.75, 31.39, 9.64; m/z (ESI) [M + H]+ 308.1, [M + Na]+  330.2. 
 
7-(Hydroxymethyl)-2H-chromen-2-one (53): 7-(Bromomethyl)-2H-chromen-2-one 52 (0.250 
g, 1.05 mmol) was dissolved in H2O (10.5 mL) and THF (10.5 mL).  It was heated at reflux 
overnight.  Work-up was done by extracting the reaction mixture with methylene chloride (2 x 
10 mL).  The organic portions were combined, and washed with saturated aqueous NaHCO3 (10 
mL) and brine (10 mL).  The organic portion was then dried over MgSO4, filtered and was 
concentrated in vacuo.  Purification of the crude mixture was done by flash chromatography 
(SiO2, 3:1 hexane: ethyl acetate) yielding 0.237 g of product 53:  
1H NMR (600 MHz, CDCl3) δ 
7.70 (d, J = 9.5 Hz, 1 H), 7.47 (d, J = 7.9 Hz, 1 H), 7.36 (s, 1 H), 7.29 (d, J = 7.0 Hz, 1 H), 6.41 
(d, J = 9.5 Hz, 1 H), 4.82 (d, J = 5.8 Hz, 2 H). 
 
2-Oxo-2H-chromene-7-carbaldehyde (54): Alcohol 53 (0.237 g, 1.34 mmol) was dissolved in 
anhydrous methylene chloride (3.4 mL) and DMSO (6.7 mL).  The reaction flask was cooled to 
0 °C in an ice bath.  Triethylamine (0.89 mL, 6.35 mmol) was added, followed by the addition 
Sulfur trioxide-pyridine (0.79 g, 4.97).  The reaction was stirred for 1.5 h.  Work-up was begun 
by addition of diethyl ether (17 mL).  The reaction mixture was then washed with H2O (14 mL), 
saturated aqueous NaHCO3 (14 mL), H2O (14 mL), and brine (14 mL).  The organic portion was 
then dried over MgSO4, was filtered and concentrated in vacuo, resulting in 0.154 g of the crude 
aldehyde 54 (66%):  1H NMR (600 MHz, CDCl3) δ 10.09 (s, 1 H), 7.81 (d, J = 7.2 Hz, 2 H), 7.76 
(d, J = 9.8 Hz, 1 H), 7.65 (d, J = 8.1 Hz, 1 H), 6.57 (d, J = 9.5 Hz, 1 H). 
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7-Vinyl-2H-chromen-2-one (15): Methyltriphenylphosphonium bromide (1.04 g, 2.88 mmol) 
was suspended in anhydrous THF (6.8 mL).  This reaction flask was cooled to -78 °C in an 
acetone/dry ice bath. nButyl Lithium (1.8 mL, 2.88 mmol, 1.6 M in hexane) was added to the 
flask.  The acetone/dry ice bath was removed, and the reaction was stirred for 3 h at room 
temperature.  In the meantime, aldehyde 54 (0.154 g, 0.883 mmol) was dissolved in anhydrous 
THF (4.4 mL).  It was cooled in an ice bath to 0 °C, and the methyl ylide was added to the 
aldehyde flask.  The reaction was allowed to stir overnight, gradually warming to room 
temperature.  The reaction was quenched with the addition of saturated aqueous NH4Cl (1.8 mL).  
The reaction was diluted with hexane (13.5 mL), and washed with H2O (2x 13.5 mL) and brine 
(13.5 mL).  The aqueous portions were combined and extracted once with hexane (13.5 mL).  
The organics were combined, dried over MgSO4, filtered and concentrated in vacuo.  The crude 
reaction mixture was purified by flash chromatography (SiO2, 9:1 hexane: ethyl acetate), 
resulting in 25 mg of isolated 15 (16%): 1H NMR (600 MHz, CDCl3) δ 7.68 (d, J = 9.5 Hz, 1 H), 
7.43 (d, J = 8.5 Hz, 1 H), 7.34 (s, 1 H), 7.34 (d, J = 7.1 Hz, 1 H), 6.75 (dd, J = 17.5, 10.9 Hz, 1 
H), 6.39 (d, J = 9.5 Hz, 1 H), 5.88 (d, J = 17.5 Hz, 1 H), 5.43 (d, J = 10.9 Hz, 1 H). 
 
3-(3-Methoxyphenyl)propanal (56): Alcohol 55 (0.549 g, 3.30 mmol) was dissolved in 
anhydrous methylene chloride (8.3 mL) and DMSO (16.5 mL).  The reaction was cooled to 0 °C 
in an ice bath.  Triethylamine (2.2 mL, 15.64 mmol) was added to the reaction flask, followed by 
addition of sulfur trioxide-pyridine (1.95 g, 12.24 mmol).  The reaction was stirred for 1.5 h at 0 
°C.  Work up was done with addition of diethyl ether (42 mL).  The reaction mixture was 
washed with H2O (33 mL), saturated NaHCO3 (33 mL), H2O (33 mL) and brine (33 mL).  The 
organic phase was then dried over MgSO4, filtered, and concentrated in vacuo, resulting 0.419 g 
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of crude aldehyde 56 (77%):  1H NMR (600 MHz, CDCl3) δ 9.81 (s, 1 H), 7.19 (m, 1 H), 6.76 
(m, 3 H), 3.78 (s, 3 H), 2.93 (t, J = 7.5 Hz, 1 H), 2.77 (t, J = 7.8 Hz, 1 H) 2.67 (m, 1 H), 1.90 (m, 
1 H). 
 
1-(But-3-en-1-yl)-3-methoxybenzene (22):  Methyltriphenylphosphonium bromide (3.00 g, 
8.42 mmol) was suspended in anhydrous THF (20 mL).  The reaction flask was cooled to -78 °C 
in an acetone/dry ice bath.  nButyl lithium (5.3 mL, 8.48 mmol, 1.6 M in THF) was added and 
the mixture was stirred for 3 h, turning orange in color. Crude aldehyde 56 (0.419 g, 2.55 mmol) 
was then dissolved in anhydrous THF (13 mL), and cooled to 0 °C.  The orange ylide mixture 
was added to the aldehyde flask, and the reaction was stirred overnight, gradually warming to 
room temperature.  The reaction was quenched by the addition of saturated aqueous NH4Cl (5.3 
mL).  The reaction was diluted hexane (40 mL).  This was then washed with H2O (2 x 40 mL) 
and brine (2 x 40 mL).  The aqueous portions were combined, and extracted once with hexane 
(40 mL).  The organics were combined, dried over MgSO4, filtered and concentrated in vacuo. 
The product was purified by flash chromatography (SiO2, 19:1 hexane: ethyl acetate) yielding 
0.207 g of product 22 at 50 % yield as a colorless oil:  1H NMR (600 MHz, CDCl3) δ 7.21 (t, J = 
7.7 Hz, 1 H), 6.80 (d, J = 7.5 Hz, 1 H), 6.76 (s, 1 H), 6.76 (d, J = 8.4 Hz, 1 H), 5.88 (m, 1 H), 
5.07 (d, J = 17.2, 1 H), 4.99 (d, J = 10.3 Hz, 1 H), 3.81 (s, 3 H), 2.71 (t, J = 7.6 Hz, 2 H), 2.39 
(dd, J = 15.0, 6.8 Hz, 2 H). 
 
(3R,4S,5S)-6-Allyl-4-((tert-butyldimethylsilyl)oxy)-3,5-dimethyltetrahydro-2H-pyran-2-one 
(23): Aldehyde 31 (0.656 g, 2.07 mmol) was dissolved in anhydrous DCM (19.7 mL) and cooled 
to -78 °C.  Titanium tetrachloride (0.23 mL, 2.11 mmol) was dissolved in anhydrous DCM (2.11 
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mL) and added drop-wise to the reaction flask.  This was followed by addition of 
allyltrimethylsilane (0.43 mL, 2.69 mmol).  The reaction was allowed to warm gradually to -20 
°C over 3 hours and 40 minutes.  A 2nd aliquot of allyltrimethylsilane (0.33 mL, 2.07 mmol) was 
added at this point, and the reaction was allowed to warm to 0 °C over 2 hours.  The reaction was 
quenched at this point by addition of saturated aqueous NaHCO3 (16.4 mL) and was extracted 
with DCM (4 x 16 mL).  The organics were combined, and trifluoroacetic acid (0.33 mL) was 
added to the organic phase.  This was shaken vigorously, and was then washed with saturated 
aqueous NaHCO3 (2 x 30 mL) and brine (2 x 30 mL).  This was then dried over MgSO4, was 
filtered, and concentrated in vacuo.  Purification was done via flash chromatography (SiO2, 19:1 
hexane: ethyl acetate) yielding 0.240 g of 23 (39%) as a mixture of two diastereomers: 1H NMR 
(600 MHz, CDCl3) δ 5.86 (m, 1 H), 5.17 (d, J = 6.5 Hz, 1 H), 5.15 (s, 1 H), 4.42 (m, 1 H), 3.66 
(t, J = 2.5, 1 H), 2.63 (qd, J = 7.62, 2.9 Hz, 1 H), 2.56 (dt, J = 14.9, 4.7 Hz, 1 H), 2.30 (m, 1 H), 
1.96 (m, 1 H), 1.25 (d, J = 7.6 Hz, 3 H), 0.98 (d, J = 6.8 Hz, 3 H), 0.88 (s, 9 H), 0.07 (d, J = 7.5 
Hz, 6 H); 13C NMR (150 MHz, CDCl3) δ 174.14, 132.56, 118.58, 80.12, 74.47, 43.94, 36.95, 
32.42, 25.70, 17.95, 16.32, 13.62, -4.53, -4.82. 
 
(1R,2S,E)-8-((3S,4S,5R)-4-((tert-butyldimethylsilyl)oxy)-3,5-dimethyl-6-oxotetrahydro-2H-
pyran-2-yl)-3-(methoxymethoxy)-2-methyl-1-phenyloct-6-en-1-yl carbamate (57): 
Carbamate 20 (29.2 mg, 0.0950 mmol) and lactone 23 (42.5 mg, 0.1425 mmol) were dissolved in 
anhydrous methylene chloride (1.9 mL).  Grubbs II ruthenium catalyst (8.1 mg, 0.00950 mmol) 
was dissolved in DCM (0.48 mL), and then added to the reaction flask.  A reflux condenser was 
attached, and the reaction was heated at reflux for 7 h.  After this, the heating was stopped, and 
the DCM was evaporated from the reaction mixture.  The residue was purified by flash 
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chromatography, (SiO2, 3:1 hexane: ethyl acetate) to yield  13 mg of 57 (24%): 
1H NMR (600 
MHz, CDCl3) δ 7.34-7.27 (m, 5 H), 5.76 (d, J = 6.8 Hz, 1 H), 5.48-5.46 (m, 2 H), 4.65 (bs, 2 H), 
4.56 (dd, J = 39.4, 6.8 Hz, 2 H), 3.64 (t, J = 2.4 Hz, 1 H), 3.39 (s, 3 H), 3.28-3.23 (m, 1 H), 2.64 
(qd, J = 7.7, 2.9 Hz, 1 H), 2.46-2.42 (m, 1 H), 2.21-2.14 (m, 1 H), 2.13-2.08 (m, 1 H), 2.06-1.96 
(m, 2 H), 1.96-190 (m 1 H), 1.66-1.58 (m 3 H), 1.24 (d, J = 7.7 Hz, 3 H), 0.99 (d, J = 6.8 Hz, 3 
H), 0.96 (d, J = 6.7 Hz, 3 H), 0.88 (s, 9 H), 0.06 (d, J = 7.1 Hz, 6 H); 13C NMR (150 MHz, 
CDCl3) 174.31, 156.08, 140.36, 133.85, 128.25, 126.79, 126.67, 124.14, 96.72, 80.54, 79.24, 
79.17, 65.84, 55.76, 43.90, 42.09, 32.61, 31.77, 25.77, 25.62, 17.95, 16.27, 15.27, 13.76, 9.66, -
4.55, -4.81; m/z (ESI) [M + H]+ 578.2, [M + Na]+ 600.2. 
 
(1R,2S,E)-8-((3R,4S,5R)-4-Hydroxy-3,5-dimethyl-6-oxotetrahydro-2H-pyran-2-yl)-3-
(methoxymethoxy)-2-methyl-1-phenyloct-6-en-1-yl carbamate (58): Analogue 57 (10.8 mg, 
0.0187 mmol) was dissolved in MeOH (4.7 mL). HCl (4.7 mL, 4 M in H2O) was added to the 
reaction flask, and the reaction was stirred for 14 h.  After this time, the reaction was diluted with 
H2O (10 mL) and poured into a separating funnel containing ethyl acetate (15 mL).  The acid 
was neutralized with the addition of saturated aqueous NaHCO3.  The aqueous was then extracted 
with EtOAc (3 x 10 mL). The organics were combined, washed with brine (10 mL) and dried 
over MgSO4.  This was filtered and then concentrated in vacuo.  The crude mixture was purified 
by flash chromatography (SiO2, 3% MeOH in methylene chloride) to yield 58 (60%)  and 59 
(54%):  1H NMR (600 MHz, CDCl3) δ 7.33-7.27 (m, 5 H), 5.76 (d, J = 6.7 Hz, 1 H), 5.48-5.46 
(m, 2 H), 4.70 (bs, 2 H), 4.56 (dd, J = 38.2, 6.9 Hz, 2 H), 4.36-4.32 (m, 1 H), 3.72 (bs, 1 H), 3.40 
(s, 3 H), 3.26 (td, J = 6.3, 3.7 Hz, 1 H), 2.68 (qd, J = 7.2, 4.5 Hz, 1 H), 2.41 (dt, J = 14.0, 4.3 Hz, 
1 H), 2.25-2.19 (m, 1 H), 2.11 (td, J = 6.8, 3.2, 1 H), 2.00-1.90 (m 4 H), 1.66-1.62 (m, 2 H), 1.30 
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(d, J = 7.3 Hz, 3 H), 1.04 (d, J = 6.9, 3 H), 1.02 (d, J = 6.9 Hz, 3 H); 13C NMR (150 MHz, 
CDCl3) δ 156.09, 133.90, 128.34, 127.68, 126.73,
 124.19, 99.97, 98.77, 96.70, 79.97, 79.11, 
73.20, 55.80, 43.09, 41.93, 35.69, 33.92, 31.75, 29.70, 28.69, 15.65, 12.41, 9.71; m/z (ESI) [M + 
H]+ 464.2, [M + Na]+ 486.1, [M – H]- 462.1. 
 
(1R,2S,E)-3-Hydroxy-8-((3R,4S,5R)-4-hydroxy-3,5-dimethyl-6-oxotetrahydro-2H-pyran-2-
yl)-2-methyl-1-phenyloct-6-en-1-yl carbamate (59): 1H NMR (600 MHz, CDCl3) 7.34-7.28 
(m, 5 H), 5.75 (d, J = 6.4 Hz, 1 H), 5.51-5.49 (m, 2 H), 4.74 (bs, 2 H), 4.35-4.31 (m, 1 H), 3.73 
(t, J = 3.4 Hz, 1 H), 3.51-3.49 (m, 1 H), 2.67 (qd, J = 7.4 ,3.9 Hz, 1 H), 2.44 (dt, J = 14.5, 5.6 Hz, 
1 H), 2.25-2.19 (m, 1 H), 2.12-2.08 (m, 2 H), 1.98-1.90 (m, 2 H), 1.64-1.48 (m 4 H), 1.30 (d, J = 
7.4 Hz, 3 H), 1.05 (d, J = 6.8 Hz, 3 H), 0.98 (d, J = 6.8 Hz, 3 H); 13C NMR (150 MHz, CDCl3) δ 
139.98, 133.92, 128.39, 128.34, 127.68, 126.40, 124.38, 120.35, 104.34, 98.77, 79.96, 78.67, 
73.38, 71.37, 44.04, 43.25, 35.61, 34.42, 33.80, 29.70, 29.12, 15.82, 12.50, 8.58; m/z (ESI) [M + 
H]+ 420.3, [M + Na]+ 442.0, [M – H]- 418.2. 
 
(1R,2S,E)-3-(Methoxymethoxy)-2-methyl-7-(2-oxo-2H-chromen-7-yl)-1-phenylhept-6-en-1-
yl carbamate 21: Carbamate 20 (30 mg, 0.0976 mmol) and lactone 15 (25mg, 0.117 mmol) 
were dissolved in anhydrous methylene chloride (1.6 mL).  Grubbs II catalyst (8.3 mg, 0.00976 
mmol) was dissolved in DCM (0.41 mL) and added to the reaction flask.  The reaction was 
heated at reflux for 10 hours.  After this, the DCM was evaporated, and the residue was purified 
by flash chromatography (SiO2, 2:1 hexane: ethyl acetate) to yield 16.6 mg of 21 (38%): 
1H 
NMR (600 MHz, CDCl3) δ 7.66 (d, J = 9.5 Hz, 1 H), 7.38 (d, J = 8.5 Hz, 1 H), 7.32-7.28 (m, 5 
H), 7.20 (s, 2 H), 6.36 (d, J = 9.5 Hz, 1 H), 6.35 (d, J = 16.1 Hz, 1 H), 6.28-6.24 (m, 1 H), 5.76 
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(d, J = 7.4 Hz, 1 H), 4.62 (bs, 2 H), 4.58 (dd, J = 52.7, 6.9 Hz, 2 H), 3.41 (s, 3 H), 3.30-3.27 (m, 
1 H), 2.22 (q, J = 3.4 Hz, 2 H), 2.14 (td, J = 7.1, 3.4 Hz, 1 H), 1.81-1.73 (m, 2 H), 1.06 (d, J = 
6.8 Hz, 3 H); 13C NMR (150 MHz, CDCl3) 161.01, 155.99, 154.46, 143.12, 141.66, 140.12, 
133.86, 129.05, 128.39, 127.87, 127.79, 126.90, 122.18, 117.58, 115.70, 113.79, 104.34, 98.77, 
96.91, 78.91, 77.74, 60.39, 55.82, 41.89, 31.64, 29.24, 14.19, 9.72; m/z (ESI) [M + Na]+ 474.1. 
 
(1R,2S,E)-3-Hydroxy-2-methyl-7-(2-oxo-2H-chromen-7-yl)-1-phenylhept-6-en-1-yl 
carbamate (60): Analogue 21 (5.8 mg, 0.0128 mmol) was dissolved in MeOH (3.2 mL). HCl 
(3.2 mL, 6 M in H2O) was added in 0.2 mL aliquots over 4 hours.  The reaction was then stirred 
for an additional 21 hours.  Work up was done by diluting the reaction mixture with H2O (6 mL).  
This was then poured into a separating funnel containing ethyl acetate (9 mL).  The acid was 
neutralized by addition of saturated aqueous NaHCO3.  The aqueous portion was then extracted 
with ethyl acetate (3 x 6 mL).  The organics were combined and washed with brine (6 mL).  The 
organics were then dried over MgSO4, was filtered and concentrated.  The crude mixture was 
purified by flash chromatography (SiO2, 3 % MeOH in DCM) to yield 60 (1.6 mg, 31%): 
1H 
NMR (600 MHz, CDCl3) δ 7.66 (d, J = 9.5 Hz, 1 H), 7.38 (d, J = 8.5 Hz, 1 H), 7.34-7.28 (m, 5 
H), 6.40-6.35 (m, 3 H), 5.74 (d, J =, 1 H), 4.63 (bs, 2 H), 3.54-3.52 (m, 1 H), 2.36-2.31 (m, 1 H), 
2.28-2.21 (m, 1 H), 2.01-1.94 (m, 1H), 1.70-1.65 (m, 1 H), 1.65-1.62 (m, 2 H), 1.04 (d, J = 6.8 
Hz, 3 H); m/z (ESI) [M + Na]+ 430.2, [M – H]- 406.2. 
 
(1R,2S,E)-3-(Methoxymethoxy)-9-(4-methoxyphenyl)-2-methyl-1-phenylnon-6-en-1-yl 
carbamate (61): Carbamate 20 (25 mg, 0.0813 mmol) and lactone 22 (15.8 mg, 0.0976 mmol) 
were dissolved in anhydrous methylene chloride (1.6 mL).  Grubbs II catalyst (6.9 mg, 0.00813 
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mmmol) was dissolved in anhydrous DCM (0.41 mL) and added to the reaction flask.  The 
reaction was refluxed for 10 hours.  After this, the DCM was evaporated, and the residue was 
purified by flash chromatography (SiO2, 4:1 hexane: ethyl acetate) to yield 12 mg of 61 (33%): 
1H NMR (600 MHz, CDCl3) δ 7.33-7.28 (m, 5 H), 7.23-7.18 (m, 1 H), 6.77-6.72 (m, 3 H), 5.73 
(d, J = 7.5 Hz, 1 H), 5.37-5.34 (m, 2 H), 4.58 (bs, 2 H), 4.54 (dd, J = 50.7, 6.9 Hz, 2 H), 3.80 (s, 
3 H), 3.37 (s, 3 H), 3.22 (td, J = 6.4, 3.2 Hz, 1 H), 2.59 (t, J = 7.5 Hz, 2 H), 2.24 (q, J = 6.9 Hz, 2 
H), 2.09 (td, J = 7.1, 3.2 Hz, 1 H) 1.92 (q, J = 7.3 Hz, 2 H), 1.64-1.63 (m, 2 H), 1.02 (d, J = 6.8 
Hz, 3 H); 13C NMR (150 MHz, CDCl3) δ 159.52, 156.04, 143.72, 140.25, 130.03, 129.92, 
129.18, 128.33, 127.77, 126.96, 120.87, 114.24, 110.91, 101.95, 101.16, 96.76, 94.79, 78.89, 
77.88, 55.74, 55.11, 41.71, 35.98, 34.17, 32.01, 28.58, 9.65, 1.00; m/z (ESI) [M + Na]+ 464.1. 
 
(1R,2S,E)-3-Hydroxy-9-(4-methoxyphenyl)-2-methyl-1-phenylnon-6-en-1-yl carbamate 
(62): Analogue 61 (5.9 mg, 0.0128 mmol) was dissolved in MeOH (3.4 mL). HCl (3.4 mL, 6 M 
in H2O) was added in 0.2 mL aliquots over 2.5 h.  The reaction was then stirred for an additional 
20 hours.  Work up was done by diluting the reaction mixture with H2O (7 mL).  This was then 
poured into a separating funnel containing ethyl acetate (10.5 mL).  The acid was neutralized by 
addition of saturated aqueous NaHCO3.  The aqueous portion was then extracted with ethyl 
acetate (3 x 10 mL).  The organics were combined and washed with brine (10 mL).  The organics 
were then dried over MgSO4, was filtered and concentrated.  The crude mixture was purified by 
flash chromatography (SiO2, 1 % MeOH in DCM) to yield 62 (1.5 mg, 29%): 
1H NMR (600 
MHz, MeOD) δ 7.34-7.28 (m, 4 H), 7.26-7.24 (m, 1 H), 7.15 (t, J = 7.7 Hz, 1 H), 6.72-6.70 (m, 3 
H), 5.61 (d, J = 7.9 Hz, 1 H), 5.39-5.34 (m, 2 H), 3.77 (s, 3 H), 2.54 (t, J = 7.6 Hz, 2 H), 2.19 (q, 
J = 6.9 Hz, 2 H), 2.01-1.98 (m, 1 H), 1.92-1.87 (m, 2 H), 1.51-1.45 (m, 2 H), 1.31-1.27 (m, 3 H), 
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1.00 (d, J = 6.8 Hz, 3 H); 13C NMR (150 MHz, MeOD) δ 161.12, 144.93, 142.19, 131.28, 
131.11, 130.19, 129.23, 128.59, 127.99, 121.88, 115.19, 112.05, 81.40, 79.39, 71.24, 55.53, 
45.46, 37.18, 35.88, 35.59, 29.95, 9.57; m/z (ESI) [M + Na]+ 420.1, [M – H]- 395.8. 
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 +Q
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B
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pray)
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440
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a
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342.2
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299.0
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236.8
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358.3
436.0
376.6
227.3
454.7
216.8
689.0
537.3
667.3
558.7
500.4
465.3
621.0
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600.5
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415.0
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9
8
7
6
5
4
3
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1.219
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1.259
1.271
2.755
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2.793
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3.234
3.239
3.256
3.261
4.064
4.078
4.083
4.092
4.102
4.114
4.126
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4.142
4.153
4.157
4.600
5.099
5.106
7.194
7.206
7.269
7.282
7.295
7.324
7.331
7.336
7.343
7.356
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7.399
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M
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D
M
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TIC
: from
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am
ple 1 (D
M
B
3-20f100) of D
M
B
3-20f100.w
iff (Turbo S
pray)
M
ax. 1.6e8 cps.
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
Tim
e, m
in
0.0
5.0e7
1.0e8
1.5e8
I n t . . .
2.34
7.70
0.26
0.67
S
him
adzu LC
 C
ontroller D
etector A
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hannel 1 from
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am
ple 1 (D
M
B
3-20f100) of D
M
B
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iff
M
ax. 5.4e5 .
0.0
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1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
10.0
Tim
e, m
in
0.0
2.0e5
4.0e5
5.4e5
A . . .
1.93
 +Q
1: E
xp 1, 1.790 m
in from
 S
am
ple 1 (D
M
B
3-20f100) of D
M
B
3-20f100.w
iff (Turbo S
pray)
M
ax. 8.3e5 cps.
200
220
240
260
280
300
320
340
360
380
400
420
440
460
480
500
520
540
560
580
600
620
640
660
680
700
m
/z, D
a
0.0
5.0e5
8.3e5
I n t . . .
322.1
528.5
266.1
361.9
216.0
253.1
510.8
448.7
567.1
278.0
414.1
306.1
391.1
475.2
259.9
339.9
494.1
537.5
585.0
679.0
432.8
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658.7
591.0
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311.4
 -Q
1: E
xp 2, 1.901 m
in from
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am
ple 1 (D
M
B
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M
B
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pray)
M
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200
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300
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400
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560
580
600
620
640
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a
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2.0e5
2.4e5
I n t . . .
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270.9
374.1
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217.2
459.9
269.0
231.7
357.7
325.1
472.0
520.0
400.7
414.9
607.8
510.8
698.0
582.6
556.9
537.8
618.7
641.0
9
8
7
6
5
4
3
2
1
ppm
−0.232
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0.878
1.286
1.297
2.668
2.684
2.690
2.706
3.188
3.193
3.210
3.216
3.669
3.682
3.696
3.975
3.978
3.990
3.993
4.141
4.153
4.164
4.241
4.244
4.254
4.827
4.839
7.166
7.178
7.197
7.209
7.221
7.256
7.260
7.268
7.280
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7.315
7.327
7.347
7.359
3.01
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1.02
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2.09
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C
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3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
10.0
Tim
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in
0.0
1.0e5
2.0e5
2.8e5
A . . .
1.94
 +Q
1: E
xp 1, 1.790 m
in from
 S
am
ple 1 (D
M
B
3-36) of D
M
B
3-36f7-13.w
iff (Turbo S
pray)
M
ax. 1.3e6 cps.
200
220
240
260
280
300
320
340
360
380
400
420
440
460
480
500
520
540
560
580
600
620
640
660
680
700
m
/z, D
a
0.00
5.00e5
1.00e6
1.28e6
I n t . . .
322.2
699.6
567.9
221.2
475.8
668.9
454.2
692.1
292.1
265.9
256.8
552.0
391.1
570.7
332.2
653.0
303.0
435.8
540.1
496.9
413.9
383.8
 -Q
1: E
xp 2, 1.901 m
in from
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am
ple 1 (D
M
B
3-36) of D
M
B
3-36f7-13.w
iff (Turbo S
pray)
M
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640
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680
700
m
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a
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1.5e4
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311.1
282.9
325.4
511.7
206.8
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218.8
281.3
515.0
549.7
248.0
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467.9
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426.9
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9
8
7
6
5
4
3
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2.434
2.442
3.424
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3.442
3.451
3.460
3.563
3.569
3.577
3.582
3.587
3.595
3.600
4.823
4.830
7.236
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7.260
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7.316
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pray)
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9.5
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5.6e5
A . . .
1.94
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3-26f8.w
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pray)
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